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ABSTRACT 
PERIVASCULAR WASTE METABOLITES CLEARANCE  
IN CENTRAL NERVOUS SYSTEM (CNS) 
 
by 
Yiming Cheng 
Efficient clearance of interstitial waste metabolites is essential for normal brain 
homeostasis. Such effective clearance is hampered by the lack of a lymphatic system in 
the brain, and the cerebrospinal fluid (CSF) is unable to clear large size waste metabolites 
in the brain. Here, a novel idea that brain arterial endothelium and smooth muscle cells 
reactivity regulates the clearance of these water-insoluble large size waste metabolites 
through the perivascular dynamic exchange, and that low dose ethanol promotes this 
perivascular clearance is proposed. 
In Aim 1, the biodistribution of a large size waste metabolite (Amyloid-β protein 
mimic) in rat perivascular space as a proof-of-concept is examined. Then the effects of 
low dose alcohol (ethanol) for promoting perivascular clearance path are evaluated. The 
result shows that ethanol increases perivascular clearance by enhancing the dilative 
reactivity of arterial endothelial cells (ECs) and alpha-smooth muscle cells (α-SMCs) via 
the activation of endothelial specific nitric oxide synthase (eNOS) and nitric oxide (NO) 
production. In Aim 2, the underlying molecular mechanisms of low dose ethanol on the 
perivascular clearance of waste metabolites is examined. The result shows that low dose 
ethanol specifically activates eNOS in arterial wall and generates physiological favorable 
level of NO without affecting the integrity of the Blood-Brain Barrier (BBB). This 
vasodilator NO stimulates the dilative reactivity of ECs- α-SMCs, which promotes 
the diffusive movement of waste metabolites from interstitial space/CSF to perivascular-
perivenous drainage path. Decrease in phosphorylation of myosin light chain in α-SMCs 
and increase in arterial vessel diameter validates α-SMCs reactivity and movement of 
waste metabolites towards perivascular space. In Aim 3, the contrast effects of chronic 
moderate alcohol intake on perivascular clearance of waste metabolites is assessed. The 
result reveals that chronic alcohol intake switches the induction of eNOS to inducible 
nitric oxide synthase (iNOS), thereby generating high level of NO. This continuous 
production of NO by iNOS in chronic alcohol exposure causes oxidative damage of the 
arterial endothelial-smooth muscle layers, and reduces dilative reactivity. Decrease in 
tight junction protein levels validates the BBB dysfunction, and increase in 
phosphorylation of myosin light chain in α-SMCs validates the impairment of α-SMCs 
reactivity, that are closely correlated with decrease in waste metabolites movement 
towards perivascular clearance path. 
The current work affords huge clinical relevance since aggregation of large size 
waste metabolites like Ab protein around the perivascular space is a hallmark of 
Alzheimer's disease. As such, the findings suggest new strategies for prevention and 
treatment of neurological diseases that are associated with clearance of entangled 
proteins.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Objective 
The objective of this dissertation is to present findings of large size waste metabolites 
clearance from brain and the underlying regulation mechanisms. Clinically, large size 
waste metabolites like tauopathy, prion-like proteinopathies, cerebral amyloid 
angiopathy, and Aβ proteins are accumulated around the perivascular space (PVS) in 
brain tissue from neurological diseases, including Alzheimer’s disease [1-3]. However, 
how these entangled proteins that originate from brain interstitial space due to neuronal 
activities translocate towards PVS and what are the underlying regulation mechanisms 
are still unknown. Here, we hypothesize that a dynamic driving force that produces by 
arterial vessel contraction/dilation creates a “pumping-like effect” within PVS, pooling 
large metabolites towards PVS and promoting their clearance from inside brain to 
systematic circulation. To validate this idea, we use low dose alcohol as a proof-of-
concept to stimulate dilative vascular reactivities. The rationale is that low dose alcohol, 
through a signaling molecule Nitric Oxide (NO), is known to induce vessel dilation [4]. 
Epidermological evidence reveal that different alcohol drinking patterns exihibit 
disctinctive corelations with onset and progression of neurological diseases that are 
associated with entangled proteins aggregation [5]. A detail discussion regarding the 
effects of alcohol will be expanded in Chapter 3-5. 
As such, to address these questions, three specific aims are evaluated:  
1) To determine the movement pattern of waste metabolites from cerebrospinal 
fluid (CSF) and interstitial spaces to perivascular spaces (PVS); 
2 
 
2)  To examine that movement of waste metabolites at perivascular spaces is 
associated with vessel dilation that regulated by interaction of brain endothelium and 
smooth muscle cells;  
 
3) To evaluate the contrast effect of low dose and chronic/moderate alcohol intake 
on perivascular clearance. 
 
 
1.2 Summary of Literatures 
The brain is the command center of the body that regulates the vital functions of 
circulation, respiration, motor function, metabolic activities, or autonomic outcomes. 
The brain coordinates these non-stop activities at the expense of huge energy utilization. 
This energy demand is achieved by active transport of nutrients across the endothelial 
blood-brain barrier (BBB). Trafficking of xenobiotics and inflammatory agents into the 
brain across the BBB or across the two other brain interfaces is harmful to brain cells, 
resulting in waste metabolites production in the interstitial space (IS). Clearance of these 
waste metabolites maintains the normal brain homeostatic functions, while aggregation 
leads to serious neurological disorders. In the absence of lymphatic system, the CSF 
flow serves as the clearance path in the CNS for water soluble peptides/solutes. The CSF 
disposal path is unable to clear large size waste metabolites, such as Aβ protein in AD. 
This section will first briefly discuss the existing entry routes of nutrients, immune cells 
or xenobiotics into the brain. Focus will be on the clearance paths and mechanisms of 
waste metabolites clearance in the CNS. This will include the mechanisms of waste 
metabolites movement from IS to perivascular clearance (PVC), from IS-CSF-PVC, and 
the exchanged from PVC to circulation. Therapeutic approach to improve the clearance 
mechanisms for ameliorating neurological diseases will be concluded finally. 
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1.2.1 Brain Barrier Interfaces  
The brain is the command center of the body. It controls the many functions of 
cardiovascular and systemic circulation, respiratory center, motor activities, metabolic 
function, renal and gastrointestinal excretion, and autonomic nervous system. 
Coordination of these numerous activities is carried out by the release of endocrinal 
chemical messengers known as hormones. The brain does this by receiving signals from 
sensory nerve cells, integrating and processing the information in interneurons, and 
sending out the message to the effector tissue organs through the motor neurons. 
Relaying of the message from the brain central nervous system to different part of the 
body through peripheral nervous system is connected by brainstem via the spinal cord. 
Constant supply of nutrients/minerals/ions across the selectively permeable blood-brain 
interface known as the blood-brain barrier (BBB) meets the energy demand of the brain. 
The localization of the tight junction proteins, protein/nutrient/ion transporters, 
multidrug resistant efflux receptors, or enzymes at the BBB, selectively maintain the 
ionic/nutrients homeostasis in the brain by dumping toxic agents in the circulation [6], 
as illustrated in Figure 1.1. Thus, small size molecules like glucose, amino acid, 
essential minerals/ions are transported across the BBB by carrier-mediated transporters, 
whereas receptor mediated transporters translocated the large size peptides and proteins 
[6, 7].  
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Figure 1.1 Routes of transport across the BBB. Passive diffusion favors lipophilic 
molecules; Carrier mediated transporters bi-directionally transport molecules influx 
and/or efflux through BBB endothelial cell layer; receptor mediated transport requires 
binding of ligand for transport of macromolecules such as glucose, peptides and proteins 
across BBB endothelium (transcytosis); paracellular pathway through tight junctions 
allows diffusion of for small molecules and cell trafficking. 
 
In addition to endothelial BBB and blood-spinal cord barrier (BSCB) interfaces, 
there are two other epithelial barriers that can render entry of molecules into the brain. 
The interface between the blood and ventricular cerebrospinal fluid (CSF) is known as 
the epithelial choroid plexus (CP), and the interface between the blood and CSF 
subarachnoid is known as the epithelial arachnoid villi [8, 9]. The main function of CP 
is the secretory source of cerebrospinal fluid for maintaining the fluid volume and ionic 
balance in the CNS. The concept is essentially justified by the fact that CP serves as the 
drainage sink in the brain. Recent findings reveal that this epithelial barrier is also 
involved in immune cell trafficking [10] and pathogens entry interface [11, 12], as such 
CP is apparently involved in the development of neurological diseases [13]. Most 
recently, Uchida et al. (2019) showed the impairment of tight junction protein claudin-
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11 expression at the BBB, at the blood-spinal cord barrier (BSCB), and at the epithelial 
arachnoid barrier in multiple sclerosis without affecting at the epithelial CP [14]. This 
finding indicates that CP barrier is unlikely involved in the development of neurological 
diseases. Choroid plexus is also implicated for supply of nutrients and signaling 
molecules to brain parenchyma, as such, it may play a role in brain development and 
aging [15]; however, this argument remains for open discussion. Another recent finding 
implicates CP as a potential BBB bypass route for drug delivery in the CNS [16]. This 
concept is based on the rationale that since carrier-mediated influx transporters or 
receptors are expressed in CP epithelium, these molecules can be designed for drug 
penetration across CP. The rationale uses the same principle that these molecules have 
been employed for drug delivery across BBB. The function of the second epithelial 
barrier known as the arachnoid villi interface between the blood and the CSF acts as the 
main drainage channels of water-soluble peptides/solutes from CSF subarachnoid to 
sagittal sinus for clearance. Intriguingly, micropinocytosis and vacuolization of 
endothelial cells present in the stromal central core of the villi seem to facilitate a 
bidirectional active transport across the arachnoid villi barrier [17].  
Out of these two endothelial (BBB and BSCB) and two epithelial (CP and 
arachnoid villi) barrier interfaces in the brain, the BBB is the primary 
transport/trafficking route of nutrients, micro-organisms, immune cells, and xenobiotic 
substances into the brain. The myeloid cells in the brain response to inflammatory event 
in the form of phagocytosis, proteolytic degradation, and autophagy, which produces 
harmful waste metabolites. Such harmful metabolites include components of 
degenerating neurons and extracellular vesicles that are entrapped in the interstitial 
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space (IS). Proper clearance of these waste metabolites from interstitial fluid/CSF 
maintains the normal homeostasis function of the brain, while aggregation leads to 
neurological disorders. Here, we focus the clearance mechanisms of these waste 
metabolites from the brain with emphasis on perivascular clearance.  
1.2.2 Interstitial Space Waste Metabolites 
The main donor of fluid in the interstitial space is the blood circulation and cellular 
secretion. The total volume of the interstitial fluid (ISF) is believed to be contributed by 
passive diffusion of fluid from the circulation. The ISF contains cellular metabolites, 
cellular shedded microvesicles and exosomes under normal condition, but ISF will 
contain entangled proteins like amyloid-β in neuropathologic condition [18]. Therefore, 
understanding the mechanisms of these waste metabolites movement from ISF to 
terminal clearance path is exceedingly important for improving neurological diseases. 
The drainage of water-soluble metabolites from ISF to CP, and to CSF compartments is 
a major route for clearance of small-size and hydrophilic substances.  
There are two school of thoughts on the mechanisms of ISF movement, the bulk 
flow and diffusive movement [19]. Cserr, et al. (1977 and 1981) showed that a bulk flow 
of the ISF independent of diffusion was responsible for clearance of waste metabolites 
in the CNS [20, 21]. Their conclusion was based on the findings that deposition of 
different molecular size tracers in rat brain interstitial space were drained at nearly 
identical half-life rates with varying diffusion coefficients. It was estimated that the rate 
of this bulk flow was 0.1–0.3 μL/g brain/min in rat brain [21, 22]. In recent time, the 
hypothesis of ISF bulk flow mechanisms has been challenged by other critiques. Sykova 
E and Nicholson C (2008) and Bakker EN et al. (2016) pointed out that the movement 
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of ISF in the interstitial spaces was attributed to diffusive movement rather than bulk 
flow mechanisms [23, 24]. Their argument was that first, the interstitial narrow spaces 
between cells are too limited to allow significant ISF bulk flow. Second, the extracellular 
matrix of the interstitial space contains repeated long chain polysaccharides like 
glycosaminoglycans, which are negatively charged, hydrophilic, and can easily trap 
water molecules and positive ions like sodium. These hindrance factors will not only 
deter the bulk flow of interstitial fluid, but also limit the movement of large size waste 
metabolites in the interstitial space. Thus, the question of whether the ISF move through 
bulk flow or passive diffusion mechanisms remains to be debated for further 
verification. Based on the emerging multiphoton imaging time-dependent interstitial 
bio-distribution of small, medium, and large size molecular weight fluorescent tracers, 
we will discuss my thought in glymphatic section below.  
1.2.3 Clearance of Waste Metabolites in Cerebrospinal Fluid (CSF) 
The cellular metabolites, extracellular vesicles, degraded peptides, and other 
degenerated cellular components contain in the interstitial fluid are mostly collected in 
the choroid plexuses (CP). The C3 compartment CP is localized in the cerebrum and C4 
is localized in the cerebellum regions of the brain. The C3 and C4 are connected by an 
aqueduct. The interstitial fluid drainage sink (CP) and ventricular cerebrospinal fluid 
(CSF) is separated by the epithelial choroid plexus barrier, through which collected 
interstitial fluid is excreted into the CSF [25]. The CSF flow passes through the 
interventricular foramina of the third ventricle to the fourth ventricle via aqueduct. From 
the fourth ventricle, the fluid then enters the subarachnoid space (SAS) through a median 
and two lateral apertures [26, 27]. The CSF containing the water-soluble waste 
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metabolites, but not cells ultimately move through the subarachnoid space and it can 
also reach to perivascular space [28, 29]. The water-soluble metabolites in the CSF 
subarachnoid space is absorbed into sagittal venous sinuses through arachnoid 
granulations. The evident came from the work of Weed et al. (1914), who found that 
non-toxic tracers injected into CSF crossed arachnoid granulations along sagittal sinus 
and eventually penetrated into dura wall of the sinus [30, 31]. The absorption of CSF 
dye arachnoid granulations was further confirmed by electron microscopy studies, 
which showed that the presence of pressure-sensitive vacuolation cycle of pores indicate 
the one-way valves transcellular flow [32]. The CSF contents in the sagittal sinus, most 
likely at the confluence of sinus exits along the myelin sheath of olfactory bulbs through 
cribriform plate [33], which is then believed to deliver into the deep cervical lymph 
nodes through nasal lymphatics [34]. This drainage path from subarachnoid space to 
nasal lymphatic system was further confirmed in seven different species using microfils 
tracers [35]. Recently, these lymphatic vessels have been investigated in rodents by 
using specific antibodies [36, 37].  
In summary, Figure 1.2 schematic presentation illustrates the intracranial CSF 
flow. It is important to emphasize here that the exchange of waste metabolites from 
subarachnoid to superior sagittal venous sinus may account only the water-soluble small 
size metabolites. This is because the granulation at the arachnoid microvilli barrier 
restrict the clearance of large size waste metabolites. As such, the clearance mechanisms 
of large size waste metabolites Aβ proteins from the interstitial space or from the CSF 
remains to be investigated. To this end, emerging findings such as the glymphatic 
hypothesis and our most recent published article on perivascular clearance mechanisms 
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revealed the clearance mechanisms of large size waste metabolites from the interstitial 
space or from the CSF circulation.  
 
 
Figure 1.2 Schematic presentation of the intracranial CSF flow. CSF is produced by 
choroid plexus and flows from the third ventricle to the fourth ventricle through cerebral 
aqueduct. After circulating over hemispheres, CSF is absorbed into superior sagittal 
sinus, transverse sinus, and sigmoid sinuses via arachnoid villi, as well as efflux from 
the CNS along olfactory nerves through cribriform plate to nasal lymphatics and 
eventually to cervical lymph nodes. 
 
1.2.4 Glymphatic System 
Glymphatic hypothesis proposed by Iliff JJ, Nedergaard M, et al. (2012) revealed the 
continuously exchange of interstitial fluid (ISF) and cerebrospinal fluid (CSF) in the 
brain compartments [29]. According to this hypothesis, the exchange is facilitated by 
aquaporin-4 (AQP4) water channels that are expressed in highly-polarized astrocytic 
end feet. In that, CSF from subarachnoid spaces fluxed into deep brain tissues along pial 
and penetrating arterioles and into the brain parenchyma towards perivenous spaces, 
which is facilitated by the convective function of astrocytic AQP4 [29, 38]. Figure 1.3 
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illustrates the convective interstitial flow towards perivenous spaces surrounding deep 
veins. They showed that water-soluble waste metabolites in ISF were collected and 
carried towards perivenous space, from where metabolites were drained to lymph nodes 
and systemic circulation.  
The evidence was shown by imaging the bio-distribution of small size (Texas Red: 
3 kD), medium size (Ovalbumin, 647 kD), and large size (FITC-d2000 kD) molecular 
weight injection in mice through cisterna magna. It was observed that the tracers rapidly 
entered the cortical pial arteries, then fluxed into perivascular spaces along the 
penetrating arterioles, which was distinguished in Tie2-GFP:NG2-DsRed double 
reporter mice. The small size tracer was found to exit primarily along the central deep 
veins and lateral-ventral caudal rhinal veins, while the medium and large size tracers 
accumulated at perivascular and peri-arterial spaces respectively in time-dependent 
manner. Using AQP4 knockout mice, this same group of investigators validated the 
proof-of-concept that astrocytic AQP4 was in part responsible for the clearance of 
radiolabeled Aβ1-40 peptide because they observed 55% reduction of Aβ1-40 peptide 
clearance in AQP4 knockout mice compared with wildtype [29, 38-40]. This idea of 
glymphatic hypothesis is further embraced by the independent studies of other 
investigators [41]. However, on the basis of time-dependent movement of tracers as 
stated above, the movement of medium to large size metabolites in interstitial fluid 
favors diffusion rather than the bulk flow mechanism of glymphatic hypothesis.   
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Figure 1.3 Movement of solutes in ISF and CSF through the glymphatic pathway. CSF 
from subarachnoid space fluxes into brain from perivascular spaces and exchanged with 
ISF. The exchange was facilitated by aquaporin-4 (AQP4) water channels that highly 
expressed in perivascular astrocyte end-foot. The bulk movement of CSF into brain 
drives the convective flow of ISF and interstitial solutes to perivenous route. 
 
The reproducibility of bulk flow mechanism is questioned by several most recent 
publications. Some investigations argued that clearance of waste metabolites in 
interstitial fluid is a passive diffusion and not a bulk flow convective transport [42, 43]. 
This argument is based on the size of metabolites. A model of diffusive and convective 
transport in brain extracellular space was designed to illustrate the validation in support 
of this argument. Findings from this model stated that diffusion alone [44] or combined 
effects of diffusion and macroscopic fluid motion [45] is responsible for transport of 
waste metabolites in brain parenchyma rather than bulk flow. The combined effects 
appear to reconcile the conflicting transport mechanisms of solutes in ISF or in 
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perivascular space. This is in parallel with the findings that cyclic changes in arterial 
pressure produces mixing of flow in opposite directions in different spaces of the arterial 
wall [46]. It is likely that convection can assist the movement of solutes into and out of 
the ISF without producing the net flow of fluid as required by glymphatic system. The 
diffusive molecular flow along the peri-arterial sheaths into subarachnoid CSF [47], and 
the diffusive drainage of waste metabolites from brain parenchyma into the basement 
membrane of capillaries [28] also argued against the glymphatic hypothesis.   
We discuss here that the transport of small size water-soluble waste metabolites 
could be mediated by glymphatic function. The missing piece is the accumulation of 
large size metabolites at the perivascular space, where glymphatic system does not 
account for the clearance mechanisms. This concept is clinically important because 
aggregation of entangled proteins at perivascular space is a hallmark of certain 
neurological diseases like Alzheimer’s disease and cerebral amyloid angiopathy [1, 2, 
48]. Unravelling the clearance mechanisms of these entangled proteins from 
perivascular to blood circulation would be novel for ameliorating the relevant 
neurological diseases. Our recent findings describe this novel clearance mechanisms at 
the perivascular space, which is discussed in perivascular clearance section.  
1.2.5 Meningeal Lymphatic Vessels 
Lymphatic system is critical for maintenance of physiological homeostasis and immune 
surveillance. It is a conventional believe that the central nervous system (CNS) lacks the 
lymphatic vessels. Recently, Aspelund et al., 2015 and Louveau et al., 2015, 
independently reported the existence of dura lymphatic vessels, known as the meningeal 
lymphatic vessels in the meninges of the brain [36, 37]. They showed this evidence by 
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positive stain of lymphatic endothelial cells marker hyaluronan receptor 1 (Lyve-1) and 
vascular endothelial growth factor receptor 3 (VEGFR3) marker along the superior 
sagittal and transverse sinuses.  
Aspelund et al., 2015, concluded that dural lymphatic vessels absorb CSF from the 
adjacent subarachnoid space and from brain ISF through glymphatic system, in which 
CSF is then transported into deep cervical lymph nodes via foramina at the base of the 
skull [36]. They validated this drainage route by nearly complete absence of tracer 
accumulation in cervical lymph nodes in transgenic mice deficient of dural lymphatic 
vessels compared with wild-type after injection of tracer into the CSF. Louveau et al., 
2015, found that the meningeal lymphatic cells were able to transport fluid and immune 
cells from the CSF and clear them to the deep cervical lymph nodes [37]. Their discovery 
of meningeal lymphatic function in the CNS becomes highly significant in the context 
of immune cell surveillance since the development of many neurological diseases 
involve inflammatory process. The findings of Aspelund et al. (2015) seems to connect 
with glymphatic hypothesis, but the CSF drainage route in meningeal lymphatic system 
appears to exit at the deep cervical lymph nodes, similar to conventional CSF exit. Here, 
we illustrate the possible connection of CSF flow, glymphatic and meningeal lymphatic 
system clearance route, Figure 1.4. Glymphatic system depicts the exchange of CSF/ISF 
waste metabolites at the perivascular space towards perivenous space, while meningeal 
lymphatic system accounts for cervical lymph nodes clearance route. 
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Figure 1.4 Connection of CSF circulation, glymphatic system and dura lymphatic 
vessels in terms of clearance. Glymphatic system (black arrow depicted flow direction) 
resided inside brain was responsible for small size water-soluble waste metabolites 
clearance (black dots). Lymphatic vessels (black circle) presented in dura was postulated 
to involve in waste metabolites clearance by granting access for waste metabolites that 
were drained by glymphatic system. 
 
It is possible that waste metabolites from perivenous space may gain access to 
meningeal lymphatics through subarachnoid or along the drainage veins that can merge 
into dura sinus. It may be still too early to embrace the meningeal lymphatic vessel as 
clearance route of CNS waste metabolites because there is no direct evidence to strongly 
support this argument. In fact, multiple paths of CSF drainage in the CNS that are 
functionally and anatomically close to lymphatic vessels were known [49-51]. However, 
the exact connection between those routes and lymphatic vessels is largely unknown. 
This is because the precise location of lymphatic vessels, whether within subarachnoid, 
inside the dura or bathed between these two layers needs to be unraveled [52].   
Since meningeal lymphatic vessels are not directly connected to CSF 
compartments, the primary route of CSF waste metabolites absorption from 
subarachnoid into sagittal sinus will be across the arachnoid villi. The arachnoid 
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microvilli barrier is permeable to small size water-soluble metabolites, as such the 
clearance mechanisms of large size waste metabolites remains to be investigated further. 
Thus, promoting the mechanisms of perivascular clearance becomes clinically 
significant since entangled proteins like A-β protein or neurofibrillary tau-
phosphorylated protein are commonly aggregated at the perivascular space.      
1.2.6 Perivascular Space Clearance Mechanisms  
Perivascular space (PVS) is referred to the space surrounding the penetrating arterioles 
when diving down into deep brain tissues from pial arteries [53, 54]. The fine structure 
of PVS consists of vascular endothelial and glial cells. The glial layer of the astrocyte 
end-feet forms the outer wall, which becomes continuous with the vascular membrane 
and basal lamina as it penetrates into the deep brain [55, 56]. The PVS channels are 
known to involve in CSF/ISF waste metabolites movement, as indicated by distribution 
of horseradish peroxidase following lateral ventricle or subarachnoid space injection in 
cats and dogs [3]. Recently, a dynamic exchange of fluorescently labeled tracer between 
CSF/ISF and perivascular was shown in NG2-DS transgenic mice by using two-photon 
microscopy imaging [29]. In fact, in the 70’s the PVS was implicated as a conduit of 
waste metabolites sink similar to the choroid plexuses because injection of horse radish 
peroxidase (HRP) tracer into striatum of rat was found to aggregate around the PVS 
[20].   
The assumption of PVS serving as a conduit sink in the CNS is significantly in 
line with the accumulation of waste metabolites around vasculatures that are clinically 
observed in certain neurological diseases. The classic examples of such waste 
metabolites deposition around the perivascular space are the neuropathological 
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observations of phosphorylated tau protein in cerebral amyloid angiopathy (CAA) and 
aggregation of amyloid beta protein in Alzheimer’s disease [1, 2, 5, 48]. These 
observations clearly suggest that PVS may be directly involved for the possible 
clearance of large size waste metabolites like phosphorylated tau protein and Aβ protein, 
which are transported by CSF, meningeal lymphatics and glymphatic function. 
Intriguingly, the ApoE family of molecules (ApoE2,E3) when mediated by low-density 
receptor protein (LRP1) seem to actively involved in the clearance of Aβ protein through 
BBB trans-vascular transcytosis [52, 57, 58]. In fact, experimental observations have 
shown that the trans-vascular clearance from brain to blood circulation across the BBB 
is believed to account for more than 80% of amyloid-beta clearance [59-61]. However, 
such findings are based on clearance of small Aβ peptide in normal physiological 
condition. In neuropathological condition, aggregation of phosphorylated tau protein 
and Aβ protein at the perivascular space still remains to be the hallmark of neurological 
diseases. The formation of this hallmark phenomenon needs further investigation to 
understand whether the aggregation of entangled proteins at the perivascular space is 
due to onsite formation or being translocated from the ISF. Since the aggregated proteins 
in AD are mostly originated from neuronal cell components, it is likely to translocate 
from the interstitial fluid rather than onsite formation. The rationale is that unlike the 
astrocyte end-feet, the location of neurons is not directly in contact with perivascular 
endothelial cells.   
Thus, we posit here two fundamental questions for further investigation. What is 
the driving force that regulate the movement of these waste metabolites towards the 
perivascular space, and how to improve the clearance of these metabolites from 
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perivascular space into the circulation in a timely manner? Understanding the improved 
mechanisms of the intertwined processes will be significant to alleviate this neurological 
disease. To this end, my recent findings gain clinical significant in understanding the 
underlying cellular and molecular mechanisms of waste metabolites movement towards 
perivascular space. We have shown that large size waste metabolite injected into the 
CSF directly or into the cortical interstitial fluid diffused towards perivascular-
perivenous space instead of clearing through the conventional CSF subarachnoid and 
sagittal sinus exchange [62]. We indicated that the hindrance for this exchange is due to 
the presence of arachnoid villi barrier between the two compartments which allows the 
absorption of mostly small size water-soluble metabolites/solutes. As a result, these 
stagnated waste metabolites are forced to move towards perivascular space, and we 
postulated that the driving force that regulate the movement appears to be the dilative 
reactivity of arterial endothelial cells and smooth muscle cells interactions.  
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Figure 1.5 Schematic presentation of waste metabolites clearance at the perivascular-
perivenous space. Arrows (orange) indicate the CSF subarachnoid flow and 
perivascular-perivenous clearance path (black) of large size waste metabolites (red dots) 
in neurodegenerative brain. Waste metabolites like β-amyloid proteins are aggregated 
more inside the interstitial space due to the lack of lymphatic system in the brain. Less 
metabolites are drained into the CSF flow due to less vessel dilative reactivity. In the 
presence of low dose alcohol (right), dilative arterial vessel reactivity promotes the 
dynamic movement of large size waste metabolites from interstitial fluid and interstitial-
CSF subarachnoid to perivascular-perivenous route. Reactivity of endothelial and 
smooth muscle cells in arteries is mediated by alcohol-elicited eNOS activation and NO 
production. From perivascular and/or perivenous spaces, large size metabolites are 
exchanged into circulation through two postulated mechanisms: (1) trans-vascular 
clearance to circulation from perivascular space, and (2) diffusion into circulation from 
perivenous space. 
 
The rationale is that reactivity of vascular smooth muscle cells was indicated to 
govern the cerebral arterial pulsation driven perivascular CSF flow locally [63]. This 
dynamic pulsatile pattern of neighboring blood vessels may exert significant attraction 
on fluid movement towards perivascular space. In this, the bioavailability of nitric oxide 
(NO), a potent vasodilator becomes essential to regulate dilative reactivity of cerebral 
arterial endothelial cells and smooth muscle cells interactions. Thus, we examined the 
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proof-of-concept that activation of brain endothelial specific nitric oxide synthase 
(eNOS) by low dose ethanol could produce favorable physiological levels of NO for 
increasing the cellular reactivity and increase diffusive movement of waste metabolites 
towards perivascular space. The rationale was that moderate level of ethanol has been 
shown to augment endothelial-SMCs dilative activity in placenta and pulmonary arterial 
vessels [4, 64, 65]. In deed my recent findings revealed that a very low dose ethanol (5.0 
mM, equivalent of 0.02% blood alcohol level) significantly enhanced the diffusive 
movement of waste metabolites from ISF/CSF to perivascular-perivenous space [62]. 
We found that dilative reactivity of brain endothelial and smooth muscle cell was the 
underlying cellular and molecular mechanisms for this improved diffusive clearance of 
waste metabolites at the perivascular-perivenous space. Figure 1.5 illustrates the 
underlying mechanisms of waste metabolites clearance at the perivascular-perivenous 
space.        
My findings also validated the exchange between perivascular-perivenous and 
blood circulation by detecting fluorescent labeled large size waste metabolite in 
systemic blood plasma after CSF/parenchyma injection. The question of whether the 
maximum diffusion into the blood circulation takes place at the perivascular space or at 
the perivenous space, and/or both remains future studies. Other studies indicated that 
perivenous flow may gain access to meningeal lymphatic vessels or large caliber 
draining veins, which may then merge to form the dura sinus [29, 39], but it has no direct 
evidence. This rationale is unlikely because lymphatic vessels appear to localize in dura 
leaflets or inside surface of the dura that are separated from the CSF, as such it will not 
have access to waste metabolites. On the basis of tissue organ environmental 
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considerations, Rapper et al. (2016) concluded that unlike the function of the peripheral 
lymphatic system, the meningeal lymphatics may not involve in CSF waste metabolites 
drainage system [52]. In summary, the movement of Aβ protein from ISF/CSF 
subarachnoid to perivascular space is regulated by dilative reactivity of brain arterial 
smooth muscle and endothelial cells interactions. This clearance path can be 
significantly promoted by low dose ethanol via eNOS-induced NO production. 
1.2.7 Conclusion 
Efficient clearance of interstitial waste metabolites in CNS is essential for normal 
maintenance of brain homeostasis. We describe here the up-to-date emerging 
discoveries of various possible clearance systems operating in the brain apart from the 
conventional cerebrospinal fluid (CSF) clearance path. This includes glymphatic 
system, meningeal lymphatic vessels, diffusive movement of waste metabolites from 
ISF/CSF to perivascular space, and perivascular clearance of waste metabolites across 
the BBB trans-vascular vessels. Each of this individual discovery does carry significant 
impact on current scientific knowledge gap towards the understanding of waste 
metabolites clearance and immune cells surveillance function in the CNS. Apart from 
the focal finding of astrocytic aquaporin-4 mediated clearance path, the glymphatic 
system does reveal the movement of waste metabolites like amyloid-beta towards the 
perivascular space.  Whether the movement of these waste metabolites from ISF/CSF to 
perivascular space is regulated by diffusion or a bulk flow mechanisms needs further 
verification. However, aggregation of waste metabolites at the perivascular space 
prompted the clearance path through the BBB trans-vascular or re-entry into the 
capillary basement membranes [66], which is relevant for eventual prevention of 
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neurological disease like Alzheimer’s disease. Thus, improving the newly discovered 
CNS clearance path(s) in the absence of traditional lymphatic drainage system assumes 
great therapeutic relevance for many neurological diseases.   
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Materials and Reagents 
Reagents: Primary antibodies rabbit anti-GFAP, iNOS, vWF, Glut-1, ZO-1, Occludin, 
Claudin-5, phospho-MLC; mouse anti-SMA, eNOS, 3-NT and anti-beta actin were 
purchased from Abcam (Cambridge, MA); anti-endomucin was purchased from 
Invitrogen (Carlsbad, CA). Rabbit anti- phosphor-MYL9, phospho-MYPT1/MYPT2 
and phosphor-MYLK were purchased from Invitrogen (Carlsbad, CA). All secondary 
Alexa Fluor conjugated antibodies were purchased from Invitrogen (Carlsbad, CA). 
Table 2.1 summarizes the details of the antibodies source, catalog numbers, and 
dilutions factors that were used for immunofluorescence staining and western blotting 
analyses.  
A highly stable fixable dextran-conjugated Fluorescein, 2,000,000 MW (FITC-
d2000) was purchased from Thermo Fisher Scientific (Waltham, MA), Nω-Nitro-l-
arginine methyl ester (L-NAME, a NOS inhibitor) was purchased from Sigma-Aldrich 
(St. Louis, MO).  
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Table 2.1 Antibodies Source, Catalogue Numbers, and Dilutions Factors for 
Immunoflurescence Staining and Western Blotting Analyses 
 
Antibody Marker Vendor Catalogue # 
Dilution 
for IHC 
Dilution 
for WB 
Anti--SMA 
 
Alpha 
smooth 
muscle actin 
 
Abcam 
ab7817 
 
1:250 1:1000 
Anti-GFAP Astrocyte 
Abcam 
 
ab7260 
 
1:250 -- 
Anti--actin Beta-actin Abcam ab8226 -- 1:2000 
Anti-Endomucin Endomucin 
Invitro
gen 
14-5851-
82 
1:200 -- 
Anti-iNOS 
Inducible 
nitric oxide 
synthase 
Abcam 
 
ab15323 
 
1:250 1:1000 
Anti- 3-
Nitrotyrosine 
3-
Nitrotyrosine 
Abcam ab110282 1:250 1:1000 
Anti-Von 
Willebrand 
Factor 
Von 
Willebrand 
Facto 
Abcam ab154193 1:250 1:1000 
Anti-Glucose 
Transporter 1 
Glucose 
Transporter 1 
Abcam ab652 1:250 1:1000 
Anti-ZO1 
ZO-1 tight 
junction 
protein 
Abcam ab96587 1:250 1:1000 
Anti-Occludin Occludin Abcam ab224526 1:250 1:1000 
Anti-Claudin 5 Claudin-5 Abcam ab15106 1:250 1:1000 
Anti- Myosin 
light chain 
(phospho S20) 
Myosin light 
chain 
(phospho 
S20) 
Abcam ab2480 1:250 1:1000 
Anti-phospho-
MYL9 (Thr18, 
Ser19) 
pThr18/Ser19 
of myosin 
light chain 2 
Invitro
gen 
PA5-
17727 
1:200 1:1000 
Anti-Phospho-
MYPT1/MYPT2 
(Ser668, Ser618) 
MYPT1/2 
(Phospho-
Ser668/Ser61
8) 
Invitro
gen 
PA5-
64805 
1:200 1:1000 
Anti-Phospho-
MYLK 
(Ser1760) 
myosin light 
chain kinase 
(MLCK) that 
contains 
serine 1760 
Invitog
en 
44-1085G -- 1:1000 
 
2.2 Methods 
2.2.1 Animals and Cell Culture 
Eight-week old male Sprague-Dawley rats were purchased from Charles River 
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Laboratory (Wilmington, MA). Animals were maintained in sterile cages under 
pathogen-free conditions in accordance with institutional ethical guidelines for care of 
laboratory animals, National Institutes of Health guidelines, and the Institutional Animal 
Care Use Committee, Rutgers University.  
For low dose/acute study: animals were randomly divided into 4 experimental 
groups (6 rats/group), 1) Control, 2) 5.0 mM ethanol, 3) 5.0 mM ethanol + L-NAME, 
and 4) L-NAME. A working concentration of 5.0 mM ethanol (EtOH, 0.230 g/kg body 
weight) was determined from a dose-dependent study of 0.046–0.460 g/kg body weight 
reconstituted in saline. 
For chronic alcohol animal model: a pair-fed procedure was employed as 
previously described [67]. In brief, rats were initially acclimated to Lieber DeCarli 
control and 29 % calorie (5% vol/vol) ethanol (EtOH) liquid-diets from Dyets Inc for 1 
week prior to weight-match pair feeding regimens for 10 – 12 weeks. Pair feeding of 
control animals (15 rats, 7 rats for acute/dose) was based on the amount of ethanol-liquid 
diets consumed by ethanol animals (8 rats). The macronutrient composition of control-
liquid diets as percent of total calories is 47% carbohydrate, 35% fat, and 18% protein; 
and that of ethanol-liquid diets is 35% fat, 18% protein, 19% carbohydrate and 29% 
ethanol caloric intake. Daily food intake and weekly body weights were recorded.  
2.2.2 Drug Concentration  
Ethanol or the NOS inhibitor L-NAME (10 mg/kg body weight) constituted in saline 
was injected through tail vein using a 27 G needle. Detailed experimental conditions for 
control tracer dye bio-distribution through cisterna magna or intracortical route of 
injection is described below. For group 2, ethanol was administered 15 min prior to 
25 
 
tracer dye injection following anesthesia, while L-NAME was administered 5 min prior 
to ethanol and 20 min prior to tracer dye injection for group 3. For group 4, L-NAME 
was given 20 min prior to tracer dye injection. 
2.2.3 Injection of Fluorescence Marker 
All rats were anesthetized by intraperitoneal injection of 0.1 ml of ketamine (80–100 
mg/kg) + xylazine (5–10 mg/kg) mixture using a 26-gauge needle as approved by the 
Panel on Euthanasia of the American Veterinary Medical Association (AVMA). 
Anesthetized rats were fixed in a stereotaxic frame. Then a total volume of 10 μl 
fluorescence tracers diluted in artificial CSF at a concentration of 5 mg/ml (0.5%) was 
injected via the cisterna magna at a rate of 2 μl/min over 5 min using 30-gauge needle 
syringe pump (Harvard Apparatus). The body temperature of animals was maintained 
at 37 °C with a temperature-controlled warming pad. Heart rate and respiratory rate were 
monitored through MouseSTAT® Pulse Oximeter & Heart Rate Monitor Module. To 
visualize the time-dependent movement of tracer from subarachnoid space into the brain 
parenchyma following cisterna magna injection, animals were perfusion fixed at 30 min, 
1 h and 2 h before surgically removing the intact brain tissues. A thickness of 40 μm 
tissue slices were cut and mounted on a glass covered slides and tracer bio-distribution 
was imaged ex-vivo by epifluorescence microscopy. 
2.2.4 Intracortical Tracer Injection 
All rats were anesthetized as describes above. A total volume of 1.0 μl fluorescent 
labeled tracers were injected stereotactically into the brain parenchyma at a rate of 
10 nl/s that controlled by a micro syringe pump (UMP3) from world precision 
instruments (Sarasota, FL). A 33-gauge needle was inserted via a small burr hole into 
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the brain at the following coordinates: right parietal skull, 2.0 mm lateral from the 
sagittal suture and 3.0 mm caudal from the coronal suture. After needle insertion, 30 min 
was given to allow the needle track to swell closed. To evaluate tracer bio-distribution, 
animals were perfusion-fixed between 1 – 4 h after injection and tissue slices (40 μm) 
were subsequently imaged as describe above. 
2.2.5 Ex-vivo Fluorescence Imaging 
Multi-channel whole-slice montages were acquired with Leica Aperio Versa 200 digital 
pathology grade slide scanner. This included separate DAPI, Green and Red emission 
channels. Exposure levels were determined based upon un-injected control slices, then 
maintained constant throughout the study. Fluorescent intensities were quantified using 
AreaQuant software specifically designed for this imaging application (Leica 
Biosystems) and expressed as average fluorescence intensity/unit area. This imaging 
technique allows for visualization of micro-structural details and digital scanning affords 
the ability to image large brain regions with no loss of resolution. In order to quantify 
fluorescence intensities, regions of interest were manually outlined in different brain 
section. For each channel (green 488 nm and red 594 nm), a minimum intensity 
threshold value was selected to exclude any background fluorescence from our 
calculation. The AreaQuant algorithm then determines if the intensity value of each 
pixel enclosed in the outlined region exceeds the minimum intensity threshold and 
outputs the total area of positive stain for each brain regions, the average intensity in 
each channel, and the expression profile of the tracers. 
2.2.6 Surgery for Two-photon in-vivo Imaging 
Rat surgery for two-photon imaging was as described by Eyo et al. [68]. Briefly, rats 
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were anesthetized and craniotomy (4.0 × 4.0 mm) was performed over the right parietal 
skull, 2.0 mm lateral from the sagittal suture and 3.0 mm caudal from the coronal suture, 
with the dura intact. A head plate was glued to the skull around the cranial window, and 
the plate was screwed into a customized stage and placed under the two-photon 
microscope. To visualize vasculatures, 1 ml BBB impermeable Texas Red-dextran 70 
(MW 70 kDa; 1% in saline, Invitrogen) was injected through tail vein 30 min before 
imaging. Rats were maintained under anesthesia and body temperature was kept at 37 °C 
with a warming pad for the duration of imaging. Heart rate and respiratory rate were 
monitored as previous described. 
2.2.7 In-vivo Imaging 
Two-photon microscopy setting and operation were as described [69]. In brief, two-
photon fluorescence microscopy (2PFM) was performed using a Bruker Ultima 
fluorescence microscope equipped with a Coherent Mira 900 laser source (200 fs, 
76 MHz). The excitation wavelength was 860 nm for dextran-conjugated FITC and 
Texas Red, and the emission was collected using two external nondescanned PMT 
detectors (NDD) at 525–600 nm. A 20 × , 1.0 N A. water immersion objective was 
employed for the 2PFM. A laser line-scan or ROI-based local excitation was used to 
better evaluate vessel diameter change and tracer movement over time. 
2.2.8 Line Scan 
To measure vessel diameters, 9000 ms X–Y line scan was conducted orthogonal to the 
vessel axis in penetrating arterioles 50–100 μm below the cortical surface. A customized 
Matlab code was developed to extract and calculate vessel diameter over time. 
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2.2.9 Immunofluorescent Staining 
For tissues: Immunostaining was described in previously publications [67, 70]. In brief, 
frozen brain tissue sections (10 μm thickness) on glass slides were washed with PBS, 
fixed in acetone-methanol (1∶1 v/v) fixative, blocked the cellular antigen with 3% bovine 
serum albumin at room temperature for 1 h in the presence of 0.4% Triton X-100 and 
incubated with respective primary antibodies such as rabbit anti-alpha smooth muscle 
actin(SMA) (1∶250 dilution), rabbit anti-GFAP (1∶250 dilution) and mouse anti-eNOS 
(1:250 dilution) for overnight at 4 °C. After washing with PBS, tissue sections were 
incubated for 1 h with secondary antibody: anti-rabbit-IgG Alexa fluor 594 (1:400 
dilution) for GFAP and mouse-IgG Alexa fluor 594 (1:400 dilution) for SMA and eNOS. 
Cover slips were then mounted onto glass slides with mounting solutions containing 
DAPI (Invitrogen), and fluorescence microphotographs were captured by Leica Aperio 
Versa 200 digital pathology grade slide scanner. 
For cells: Immunostaining procedure was described in previously publications 
[67, 70]. In brief, cells cultured on glass slides were washed with PBS, fixed in 
paraformaldehyde (4%) fixative, blocked the cellular antigen with 3% bovine serum 
albumin at room temperature for 1 hr in the presence of 0.4% Triton X-100 and 
incubated with respective primary antibodies for overnight at 4°C. After washing with 
PBS, cells were incubated for 1 hour with secondary antibody. Cover slips were then 
mounted onto glass slides with mounting solutions containing DAPI (Invitrogen), and 
fluorescence microphotographs were captured by Leica Aperio Versa 200 digital 
pathology grade slide scanner. 
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2.2.10 Western Blot 
A cerebral blood vessel isolation was performed using mesh filtration to concentrate 
protein content that originated solely from vasculatures [71]. In brief, fresh brain tissue 
was homogenized on ice using pestle in HBSS solution with 1% HEPES. Whole brain 
homogenization was centrifuged at 2,000×g for 10 min and 4,400×g for 15 min (in 20% 
dextran) at 4 °C. Then, pellet containing vessels was re-suspended into ice-cold 1% 
bovine serum albumin (BSA) solution and proceed to mesh filter (20 um) for isolation. 
Western blot was performed as described by previous publication [72]. In brief, isolated 
brain vessels or cell lysis from respective experimental conditions were lysed with 
CellLytic-M (Sigma) for 30 min at 4 °C, and centrifuged at 14000×g. The concentrations 
of protein from tissue homogenates were estimated by bicinchoninic acid (BCA) method 
(Thermo Fisher Scientific, Rockford, IL). Protein load was 20 μg/lane in 4–15% SDS-
PAGE gradient gels (Thermo Fisher Scientific). Molecular size separated proteins were 
then transferred onto nitrocellulose membranes, blocked with superblock (Thermo 
Fisher Scientific), and incubated overnight with respective primary antibody to alpha-
SMA, eNOS and beta-actin (all diluted at 1:1000) at 4 °C, followed by washes and 
incubation with horse-radish peroxidase conjugated secondary antibodies 
(corresponding to primary, diluted at 1:12000) for 1 hr at room temperature. 
Immunoreactive bands were detected by West Pico chemiluminescence substrate 
(Thermo Fisher Scientific). Data was quantified as arbitrary densitometry intensity units 
using the ImageJ software package. 
2.2.11 Real-time NO Detection 
For tissues: Briefly, freshly isolated brain tissues was prepared in ice-cold oxygenated 
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(95% O2 and 5% CO2) artificial cerebrospinal fluid (aCSF). Coronal slice (1 mm) was 
prepared using brain matrices and transferred to a recovery chamber for 30 min with 
oxygenated aCSF at 37 °C temperature before experiment. NO was measured using free 
radical analyzer with a specific NO probe (TBR4100, World Precision Instruments, 
Sarasota, FL). The NO probe is able to polarographically measure the concentration of 
NO gas in solutions. The system was calibrated using different concentrations of NO 
donor S-Nitroso-N-acetyl-dl-penicillamine (SNAP, Cayman Chemical) to generate a 
standard curve. To block endogenous NO, oxygenated aCSF containing 1 mM L-NAME 
was added to tissue 30 min prior experiments. Probe was positioned ~1 mm above tissue 
surface using a micromanipulator (World Precision Instruments, Sarasota, FL) and 
baseline of NO release was recorded prior EtOH treatment. Tissue was then treated with 
5 mM EtOH (in aCSF) and subsequently with 1 mM L-NAME (in aCSF). NO 
concentration was recorded using NO probe as described at the same time. Experiment 
was simultaneously performed with control from the same tissue source to exclude 
experimental drift in NO release unrelated to the study. 
For cells: To block endogenous NO prior experiment, cells were firstly incubated 
with medium containing 50 µM L-NAME for 30 min. During experiment, probe was 
positioned ~ 1 mm above cell layer surface using a micromanipulator (World Precision 
Instruments, Sarasota, FL) and baseline of NO release was recorded prior EtOH 
treatment. Cells were then treated with 10 mM EtOH or 15 µM SNAP (in medium) and 
data was collected at 10, 20, 30, 60 and 120 min respectively. Experiment was 
simultaneously performed with control from the same cell source to exclude 
experimental drift in NO release unrelated to the study. 
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2.2.12 Plasma Fluorescence Intensity 
Whole blood was collected from the tail vein before sacrificing and stored in citrate-
treated blood tubes (Fisher) to avoid coagulate. To extract plasma, whole blood was 
centrifuged at 1000×g for 10 min (4 °C). Clear supernatant was carefully collected and 
aliquoted into small tubes. Arbitrary fluorescence intensity was determined in 96-well 
plate using plate reader (Molecular Devices) at 490 excitation and 525 emission 
wavelengths. 
2.2.13 Endothelial and Smooth Muscle Cells Culture 
Rat primary brain vascular endothelial cells and were purchased from ScienCell 
(Carlsbad, CA) and rat primary brain vascular smooth muscle cells were purchased from 
Cell Biologics (Chicago, IL). Briefly, cells were cultured on collagen-coated flash in 
complete medium with supplements provided by vendor.  
2.2.14 Cell Toxicity Assay 
Endothelial cells and smooth muscle cells (1×104/well, determined by cell number 
titration) were seeded into a 96-well plate respectively and incubated in at 37°C under a 
humidified atmosphere of 5% CO2 and 95% air for 24 hours prior experiment to allow 
fully attachment. Cells were then incubated with medium containing different 
concentration of alcohol (0, 2.5 mM, 5 mM, 10 mM and 20 mM) for 2 hours. Toxicity 
was subsequently measured by using MTT assay kit (Abcam). In brief, adding 50 μl of 
MTT reagent to each well, and then incubated the plate at 37°C for 3 h. After incubation, 
150 μl of MTT solvent was added to each well and absorbance was measured at 590 nm 
using a multi-well spectrophotometer (Molecular Device). 
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2.2.15 Data Analysis 
All results values are expressed as the mean ± SE, N = 6. Statistical analysis of the data 
was performed using SPSS 24 (IBM). In the present studies, wherever the numeric 
values of N are indicated, it represents the actual number of animals/samples used for 
that specific experiments or the actual number of experiments performed in cell culture 
setting, and not the number of replicates per experimental condition. Comparisons 
between samples were performed by ANOVA with Tukey’s post-hoc tests. Differences 
were considered significant at *p < 0.05. 
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CHAPTER 3 
ALCOHOL PROMOTES WASTE CLEARANCE IN THE CNS VIA BRAIN 
VASCULAR REACTIVITY  
 
3.1 Summary 
The efficient clearance of the interstitial waste metabolites is essential for the normal 
maintenance of brain homeostasis. The brain lacks the lymphatic clearance system.  
Thus, the drainage of waste metabolites in the brain is dependent on a slow flow of 
cerebrospinal fluid (CSF) system. Glymphatic system claims the direct bulk flow 
transport of small size water-soluble waste metabolites into to the perivenous space by 
aquaporin-4 water channels of the astrocyte end-feet, but it did not address the diffusive 
clearance of large size waste metabolites. In this chapter, we addressed the clearance 
mechanisms of large size waste metabolites from interstitial fluid to perivascular space 
as well as from CSF subarachnoid into perivascular space via the paravascular drainage. 
A low dose ethanol acting as a potent vasodilator promotes the dynamic clearance of 
waste metabolites through this perivascular-perivenous drainage path. We observed that 
ethanol-induced increased in vascular endothelial and smooth muscle cell reactivity 
regulated the enhanced clearance of metabolites. Here, we found that activation of 
endothelial specific nitric oxide synthase (eNOS) by ethanol and generation of 
vasodilator nitric oxide mediates the interactive reactivity of endothelial-smooth muscle 
cells and subsequent diffusion of the CNS waste metabolites towards perivascular space. 
By detection of tracer dye (waste metabolite) in the perivenous space and in the blood 
samples, I further confirmed the improved clearance of waste metabolites through this 
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unraveled interstitial-perivascular-perivenous clearance path. As such, we conclud that 
alcohol intake at low-dose levels may promote clearance of neurological disease 
associated entangled proteins.   
 
3.2 Background 
Efficient clearance of interstitial fluid (ISF) waste metabolites by cerebrospinal fluid 
(CSF) flow is essential for normal healthy maintenance of brain homeostasis, because 
unlike most tissue organs the brain lacks a lymphatic system. The classical view of the 
CNS clearance system is that the interstitial fluid (ISF) contains the extracellular and 
intracellular waste metabolites that are drained into choroid plexus [31], from here CSF 
flows into subarachnoid space (SA) through the median and lateral apertures. CSF is 
then exchanged into dural sagittal sinuses via a restricted granulation known as 
subarachnoid microvilli, then the sagittal sinuses, merged at the confluence of sinuses, 
are drained into nasal or cervical lymphatic vessels [26, 27, 30]. Johnston et al. (2010) 
showed this path by filling the subarachnoid compartment of seven different species, 
from small rodents to humans, with yellow microfil CSF tracer dyes to trace the drainage 
path of CSF into nasal lymphatics [35]. They found that microfil was observed primarily 
in the subarachnoid space around the olfactory bulbs and cribriform plate. The contrast 
agent followed the olfactory nerves and entered extensive lymphatic networks in the 
submucosa associated with the olfactory and respiratory epithelium.  
Recently, Louveau et al. (2015) and Aspelund et al. (2015) have shown the 
existence of dura associated lymphatic vascular system in the brain's meninges whole-
mount fixing the meninges still attached to the skull [36, 37]. They observed distinctive 
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expression of lymphatic endothelial cells including lymphatic vessel endothelial 
hyaluronan receptor 1 (Lyve-1) and vascular endothelial growth factor receptor 3 
(VEGFR3) along the blood vessels of superior sagittal and transverse sinuses. The 
involvement of dural lymphatic vessels for the drainage of metabolites in dural venous 
sinus was shown by injecting tracers into the CSF of animals and by detecting the tracers 
in the lumen of Lyve-1-expressing vessels and in the deep cervical lymph nodes [37]. It 
was further confirmed that there was a significant reduction of tracers in Lyve-1-
expressing vessels and a complete absence of tracers in the cervical lymph nodes of 
transgenic mice deprived of lymphatic vessels [36]. Since anatomical sites of lymphatic 
vessels were strictly localized in brain dura meninges [36, 37, 52], as such transport of 
soluble waste metabolites into lymphatic vessels would be dependent on CSF 
subarachnoid circulation. Notably, the exchange of waste metabolites from 
subarachnoid to superior sagittal venous sinus is valid only for water-soluble small size 
metabolites because of granulated subarachnoid microvilli barriers. Thus, dural 
lymphatic vessels, also known as meningeal lymphatic clearance system may not clear 
large size waste metabolites.  
The recently discovered glymphatic system showed a molecular size dependent 
clearance profile of fluorescent dye tracers in the CNS, when tracers were injected 
through intracisterna magna [29]. The small size tracer (Texas Red, 3 kDa) directly 
entered the interstitial space and influx into the perivascular space along penetrating 
arterioles. The clearance of this small size tracer from perivascular space into central 
deep veins and lateral-ventral caudal rhinal veins is facilitated by aquaporin-4 (AQP4) 
water channel of a highly-polarized astrocytic end feet. Such an AQP4 facilitated 
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exchange between CSF and ISF is restricted to small size waste metabolites because the 
medium size tracer (Ovalbumin, 647 kDa) gets accumulated at perivascular space within 
3 hours of injection. The tracer then slowly penetrated into the basement membranes of 
parenchymal capillaries and perivascular space of large caliber draining veins, 
suggesting a capillary-venous drainage route. In contrast, a large size tracer (FITC, 2000 
kDa) was found to be aggregated at the perivascular space, lacking a distinct clearance 
path [29]. Injection of radiolabeled amyloid β1–40 (Aβ, a small peptide) into mouse 
striatum was rapidly cleared through the glymphatic pathway since the clearance was 
significantly diminished in AQP4 deficiency transgenic mice [29]. This further 
implicates the importance of glymphatic system clearance in neurological disease, like 
Alzheimer’s disease [29, 38-40], even though glymphatic system did not account for the 
clearance of such large size waste metabolites in the CNS. 
However, the reproducibility of the accredited bulk flow transport mechanism of 
glymphatic hypothesis has been questioned by a number of most recent verification 
studies. These investigations concluded that clearance of waste metabolites from the 
brain is more of a diffusion rather than bulk flow convective transport, based on the 
metabolites molecular size [42, 43]. In support of this argument, a model of diffusive 
and convective transport in brain extracellular space stated that diffusion alone size [44] 
or combined effects of diffusion and macroscopic fluid motion [45] is adequate to 
account for transport of waste metabolites in brain parenchyma rather than bulk flow 
alone. The later appears to be a more reconcile argument for such conflicting 
experimental observations, notably the transport of solutes in opposite directions in the 
perivascular space. This is in parallel with the findings that cyclic changes in arterial 
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pressure produces mixing or flow in opposite directions in different spaces of the arterial 
wall [46]. In this case, convection can assist the movement into and out of the cortex 
without necessarily producing the net flow of fluid into the cortex as required by 
glymphatic system. Furthermore, the diffusive molecular flow along the peri-arterial 
sheaths into subarachnoid CSF [47], and the diffusive drainage of waste metabolites 
from brain parenchyma into the basement membrane of capillaries [28] argued against 
the glymphatic hypothesis.   
The fact is that large size waste metabolites like tauopathy, prion-like 
proteinopathies, cerebral amyloid angiopathy, and Aβ proteins are seen accumulated 
around the perivascular space in brain tissue from neurological diseases [1, 2, 48]. Such 
observations suggest that large size waste metabolites are not cleared by CSF, 
glymphatic, or meningeal lymphatic systems. Here, we address the fundamental 
questions of what dynamic force specifically drives the movement of these waste 
metabolites towards perivascular space, and can we strategize to enhance the clearance 
of these waste metabolites from perivascular space into the circulation? It has been 
shown that the blood-brain barrier (BBB) trans-vascular clearance from brain to blood 
provides functionally a major pathway for elimination of different waste metabolic 
products from brain into the circulation including amyloid-beta, which is believed to 
account for > 80% of amyloid-beta clearance under physiological conditions [59-61]. 
Thus, uncovering the mechanisms of moving the waste metabolites towards perivascular 
space and the clearance of waste metabolites from perivascular space into the circulation 
should have significant clinical impact for possible prevention of many neurological 
diseases. We hypothesize that increasing the reactivity of brain arterial endothelial and 
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smooth muscle cell function by low dose ethanol can enhance the dynamic diffusion of 
water-insoluble large size CSF/interstitial metabolites into perivascular space and 
subsequent clearance into the circulation. Here we test the idea that activation of brain 
endothelial specific nitric oxide synthase (eNOS) by low dose ethanol produces potent 
vasodilator nitric oxide that can diffuse readily into the underlying SMCs to cause 
arterial vessel dilation through intracellular calcium signaling. The rationale is that 
activation of eNOS by low concentration of ethanol elevates physiological NO levels 
and augments endothelial-SMCs interactive reactivity [4, 64, 65]. This eNOS derived 
NO acts as a potent protective brain vascular tone and vasodilation [70]. 
 
3.3 Results 
In this study, we examined the idea that reactivity of endothelial and smooth muscle 
cells plays a critical role in the interstitial-perivascular-perivenous clearance of large 
size waste metabolites in the brain. Here we first focused on the dynamic bio-distribution 
of a 2000 kDa fluorescent dye representing large size waste metabolites following two 
different routes of injection, through cisterna magna and direct intracranial cortical 
injection. Cisterna magna route directly deposits the tracer into the C3 region of CSF-
subarachnoid flow, while deposition of tracer dye into the intracranial cortical region 
move through the interstitial space. Stimulation of brain arterial endothelial and smooth 
muscle cells reactivity by low dose ethanol was correlated to increase clearance of waste 
metabolite through interstitial-perivascular-perivenous space. We observed that reactive 
vascular endothelial-smooth muscle cell dilation and contraction regulates the diffusion 
and clearance of waste metabolites via the interstitial-perivascular-perivenous path. The 
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clearance path is supported by the present findings. 
3.3.1 Injection of FITC-d2000 into C3 Region of CSF Flow Accumulates in 
Perivascular Space via the Subarachnoid-paravascular Movement 
 
To evaluate the movement pattern of large size waste metabolites in the brain, we first 
injected FITC-d2000 (MW: 2000 kDa) directly into the CSF flow via cisterna magna 
which bypass the interstitial movement. This large size fluorescence tracer represents 
large size waste metabolite like A-β proteins, which is validated in Appendix E (Figures 
E1 and E2). We then evaluated the bio-distribution of tracer in the brain at different 
time points. We observed that a direct deposition of tracer into the C3 region of CSF-
subarachnoid flow and penetrated into the perivascular space via the paravascular route 
time-dependently. For example, in less than 30 min after intracistertna magna injection, 
the subarachnoid (SAS) was filled with fluorescence tracer, but very little tracer 
penetrated in less than 0.5 mm depth of paravascular area from SAS (Figure 3.1A). But 
after 60 min, more tracer was observed penetrating deep into brain perivascular space 
(Figure 3.1B – C). The magnified imaging data from Figure 3.1D – F showed the 
biodistribution of aggregated tracer along the different segmental branches of arterial 
vessel. These data suggest that waste metabolites from CSF flow can move into 
perivascular space through subarachnoid-paravascular drainage path. 
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Figure 3.1 Tracer bio-distribution after cisterna magna injection at 30, 60, and 120 min. 
[A-C] data indicated that tracer was firstly filled in SAS (t<30min), and subsequently 
penetrated into brain along vasculatures. [D-F] details the magnified view of 
vasculatures in the boxed in C. Data are representative of  N=6 animals. Scale bar: [A, 
B and C] 3 mm; [D, E and F]: 50 µm. 
 
We then evaluated the exact location of the tracer in perivascular space. The 
arteriole perivascular space consists of endothelial cells, pericytes, and smooth muscle 
cells including basement membrane proteins that are ensheathed by astrocytic end-feet 
from the brain side. The capillary perivascular space will contain all cellular components 
like in arteriole but there is absence of smooth muscle cells. Co-localization of this tracer 
with immunostaining of perivascular cellular markers indicated that the waste 
metabolite tracer was found to be entrapped in between astrocytes (Figure 3.2A, GFAP) 
particularly at the astrocytic end-feet (Figure 3.2 B & C) and vascular smooth muscle 
cells (Figure 3.2D – G) as indicated by colocalization of alpha-SMA and tracer. I also 
observed that the waste metabolite tracer did not readily cross the blood vessel but 
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aggregated around perivasculature at early time point as shown in Figure 3.2E – G. 
These observations seen in immunostaining colocalization studies were further 
confirmed by multiphoton imaging techniques (Figure 3.2 H, H1, H2 & H3; Green: 
FITC-d2000, CSF tracers; Red: Texas red-d70, label vasculatures). 
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Figure 3.2 Co-localization of FITC-d2000 after cisterna magna injection with astrocyte 
marker (GFAP) and vascular smooth muscle marker (alpha-SMA) revealed location of 
tracers relative to vasculatures. [A]: Co-localization of tracer (FITC-d2000, 120 min 
after cisterna magna injection) and astrocytes (GFAP). [B and C]: Detail views revealed 
that tracers were wrapped by astrocytic end-feet (white arrows). [D] Co-localization of 
tracer (FITC-d2000, 120 min after cisterna magna injection) and smooth muscle cells 
(alpha-SMA). [E – G]: Detail views on right revealed that tracers were outside smooth 
muscle layer, not in vessel lumen. [H]: Two-photon scanning of tracer bio-distribution 
(Green: FITC-d2000; Red: Texas-Red d70). Animals were injected with two types of 
tracers: FITC (green) was delivered through cisterna magna; Texas-Red (red) was 
injected through tail vein to label vasculatures. 2 hours were allowed before sacrificing. 
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[H] indicated location of vessel segments that presented in H1, H2 and H3. Data 
suggested that after cisterna magna injection, tracers aggregated along vasculatures. 
Data was representation of N=6 animals. Scale bar: [A and D]: 3 mm; [B and C]: 100 
μm; [E, F and G]; [H]: 3 mm; [H1 and H2]: 50 µm; [H3]: 25 µm. 
 
3.3.2 Intracranial Cortical Injection of FITC-d2000 Reaches the Perivascular 
Space Prior to Subarachnoid Clearance Path 
 
In contrast to deposition of waste metabolites directly into the CSF flow through cisterna 
magna injection, we also injected a FITC-d2000 tracer directly into brain interstitial 
space at the depth of 0.5 mm in the right cortical surface, 2.0 mm lateral to sagittal suture 
and 3.0 mm away from caudal coronal suture at different time points. The rationale was 
to determine if waste metabolites can diffuse directly into the perivascular space from 
site of production (parenchyma) or the route of translocation would follow the path of 
CSF flow via subarachnoid-paravascular clearance. We found that tracers started to 
diffuse directly into para-and peri-vascular space from interstitial space after 60 min of 
cortical injection, as indicated by Texas red-d70 labeled for vasculatures and FITC-
d2000 Green representing large size waste metabolites (Figure 3.3B – D). At this time 
point, no tracers were detected at subarachnoid space through this route of injection 
(Figure 3.3A), indicating that waste metabolites can move directly into PVS via the 
interstitial diffusion. There was more accumulation of tracer in the perivascular space at 
longer time points of 240 min (Figure 3.3E – F). This cumulative aggregation of tracer 
in the PVS was from interstitial movement and dynamic translocation of CSF flow 
because subarachnoid space was also filled with tracer at this later time point. Co-
localization of tracer and vascular smooth muscle marker (alpha-SMA) immunostaining 
revealed that most of the tracer was arterial and capillary structures (Figure 3.3G – H). 
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Figure 3.3 Intracortical deposition of FITC-d2000 (green) directly into cortex (0.5 mm 
below cortical surface) allow us to track the time-dependent diffusion of tracer along the 
perivascular space marked by vessel marker Texas-Red d70 injected through the tail 
vein. 45 µm brain slices on glass slides were subjected to fluorescence microscope. [A, 
B, and E] indicate the time-dependent location of tracer. Small traces of tracers were 
already translocated from site of injection to the perivascular space before reaching to 
CSF, indicated by the absence of fluorescence in SAS. More tracers were found to move 
at longer time (E). Detail view in [C, D, F] suggested that the accumulation of tracers at 
PVS. [G and H]: co-localization of tracer (green) with smooth muscle actin (red) 
indicated that these vessels were arterials due to the presence of smooth muscle cell. 
Data are representative of N=6 animals. Scale bar: A: 1 mm; B and E: 300 µm; C, D, F 
and G: 50 µm; H, I and J: 30 µm. 
 
 
3.3.3 Evaluation of the Putative Mechanisms of Tracer Movement Towards 
Perivascular Space 
 
We then evaluated the putative mechanism of dynamic waste metabolites movement 
towards PVS that could be associated with clearance path. Based on previous findings 
[23, 28, 66, 73], we rationalized that increase in arterial vessel dilative reactivity by low-
dose alcohol may regulate the movement of waste metabolites towards PVS. The 
justification was that low dose alcohol was known to enhance vessel dilation through 
nitric oxide (NO) production in endothelial cells [74]. As such, we first established the 
45 
 
dose-response of ethanol concentrations from 2 – 10 mM on the tracer movement from 
CSF to perivascular space. We determined 5 mM ethanol gave the maximal 
biodistribution of tracer and this optimal working concentration is approximately 
equivalent of 0.02% blood alcohol level, which is about 4 – 5 times lower than the legal 
limit of 0.08 – 1.0% blood alcohol level. We observed that low dose of 5 mM ethanol 
injection into rat via the tail significantly (p<0.05) enhanced the movement of the 2000 
kDa FITC tracer from CSF to PVS compared with control (Figure 3.4A). Three 
different regions of brain slices were selected according to rat brain atlas map (Figure 
3.4A), and we observed a similar trend of increased distribution of tracer by ethanol in 
all the three different brain regions. However, this stimulating effect of ethanol was 
reversed by nitric oxide synthase inhibitor L-NAME, indicating that low dose ethanol 
increased the movement of tracer through NOS mediated NO production. 
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Figure 3.4 [A] Bio-distribution of tracer at 2 hours after cisterna magna injection in 
control, 5 mM EtOH, and L-NAME + 5 mM EtOH. Coordination of brain coronal tissue 
slices (45 µm) are shown according to rat brain map in three different locations, where 
bio-distribution of tracer was imaged in the whole brain section. Scale bar: 2 mm. [B] 
The quantity of tracer distribution in brain was calculated as mean fluorescence intensity 
on each slide (from N=6 animals, 10~15 slices were taken from each animal, +SEM). 
Data indicated that alcohol significantly increased the biodistribution of tracer and 
vascular reactivity, while NOS inhibitor L-NAME reversed the effect compared with 
control (*p<0.05).  
 
Thus, among all isoforms of NOS, we evaluated the effects of 5.0 mM ethanol on 
qualitative and quantitative levels of endothelial specific eNOS, and subsequent 
production of NO levels in brain tissues. This biological marker was examined to 
validate the idea that low dose ethanol enhanced the movement of waste metabolites 
along the perivasculature through NO induced vessel dilative pathway. Interestingly, 
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immunostaining revealed a huge increase of eNOS induction by low dose alcohol group 
(Figure 3.5A), which was further validated by significant elevation of eNOS levels by 
ethanol compared with control (p<0.05), as determined by Western blot analysis (Figure 
3.5B). To correlate the low dose ethanol-induced eNOS activation with NO generation, 
we analyzed the real-time NO production in live rat brain tissue by Free Radical 
Analyzer (World Precision Instruments, Sarasota, FL) using a micro-sensor detector. In 
line with eNOS activation, low dose alcohol exposure significantly elevated the 
production of NO in rat brain compared with baseline (Figure 3.5C). As expected, co-
treatment of L-NAME not only inhibited the induction of eNOS but also the production 
NO level. These data collectively suggest that low dose alcohol can promote 
perivascular clearance of waste metabolites through eNOS-mediated NO production by 
increasing the cerebral arterial vessel dilations. 
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Figure 3.5 Induction of eNOS by low dose ethanol produces endothelial derived nitric 
oxide. [A] Left: Colocalization of eNOS (red) and tracer (green) in whole brain tissue 
slice. Right: detailed view in boxed area. Data indicated that eNOS was elevated by 
EtOH. (N=6 animals, 10~15 slices per animal). Scale bar: Left: 3mm; Right: 50 µm. [B 
and C] The quantity of tracer distribution in brain was calculated as mean fluorescence 
intensity on each slide (from N=6 animals, 10~15 slices were taken from each animal, 
+SEM). Fluorescence intensity quantification of eNOS was calculated as mean 
fluorescence intensity on each slide (from N=6 animals, 10~15 slices were taken from 
each animal, +SEM) and presented as bar graphs for both whole brain scanning [B] and 
arterial vessel cross-section [C]. Data indicated that both quantification showed 
statistically significance upregulation of eNOS by low dose EtOH. Magnitude of 
increase in eNOS levels in the whole brain area quantification is similar to that of 
Western blot analyses. Whereas, the fold increase in arterial vessel is much higher than 
that of whole brain or Western blot because localization of eNOS is specific to arterial 
endothelium. [D] Western blot analysis of eNOS levels in different experiment 
conditions. Data was analyzed using image J to obtain arbitrary densitometry intensity 
units. Three replicates were done for each animal sample from N=6 animals. Bar graphs 
data were quantified from the ratio of eNOS to that of β-actin bands, and expressed as 
mean ±SEM. [E] Real-time NO production in live rat brain tissue (1 mm) by Free 
Radical Analyzer, where NO production was simultaneously monitored. Bar graphs 
show the average NO concentration under each condition, and expressed as mean 
±SEM. The asterisk indicates the statistical significance (*p<0.05) in EtOH compare 
with control. 
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3.3.4 Low Dose Alcohol Enhances Dynamic Vessel Dilation 
To validate the proof-of-concept that ethanol-induced arterial vessel reactivity promotes 
the pool of waste metabolites along the PVS, we determined dynamic dilative vessel 
reactivity by multiphoton imaging in live animals. We found that low dose alcohol 
significantly increased tracer movement towards PVS within 15 min, where the flux of 
tracer could be detected easily in the depth of 50 – 100 µm below cortical surface 
(Figure 3.6A). This increase in tracer accumulation in the PVS in the presence of 
alcohol was further supported by a significant vessel dilation (Figure 3.6B - C) and a 
significant increase in arterial vessel diameter (Figure 3.6D) as revealed by two photon 
line scan. This alcohol-induced significant increase in arterial vessel dilation and 
contraction suggest the active interaction between brain endothelial cell and smooth 
muscle cell within the arterial cellular components via the signaling molecule eNOS-
elicited NO production. Such a cross-talk between endothelial cell and smooth muscle 
cell is unlikely to occur in the capillary since smooth muscle cells are absent in the 
capillary. 
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Figure 3.6 Low dose alcohol enhances dynamic vessel dilation: [A] Time-lapse in-vivo 
two-photon imaging of florescent tracer (green, injected via intracisterna) and vessel 
marker Texas-Red (injected via tail vein) showed the time-dependent aggregation of 
tracer in perivascular space in 50-100 µm below cortical surface. [B] Dynamic imaging 
of changes in vessel diameter over time (N=3) before and after exposure to 5 mM ethanol 
at different time lapse. [C] Left: Cerebral was visualization of cerebral vasculature by 
two-photon imaging after intravenous tail vein injection of Texas Red-d70 showing 
penetrating arteriole in box (25 µm in diameter). Right: Selected area for X-T line scan 
to examine the changes in vessel dimeter, which was analyzed by customized Matlab at 
different time lapse. [D] Calculated changes in vessel dimeter, wherein baseline was 
collected before alcohol exposure. A 9000 ms epoch line scan was applied every 15 
minutes to determine the changes in vessel diameter, which is shown in bar graphs. Two-
way ANOVA with tukey’s post-hoc test show the statistical significance * p<0.05 
compared with baseline, expressed as mean ±SEM, N=3. 
 
We then examined the idea that generation of the alcohol-induced vasodilator NO 
from brain endothelial cells can readily diffuse into the underlining smooth muscle cells 
(SMCs) reactivity. The rationale is that elevation of physiological NO levels in 
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endothelial cell augments the endothelial-SMCs interaction to increase arterial vessel 
dilation. The qualitative data from immunostaining staining of α-SMCs showed an 
increase reactivity in low dose alcohol group compared with controls (Figure 3.7A), 
which was in agreement with alcohol-induced NO production by endothelial cells. In 
parallel with an increase α-SMCs expression, the quantitative assay by Western blot 
analysis validated the significant elevation of α-SMCs levels in alcohol condition 
compared with controls (Figure 3.7B). This data suggests an active interaction between 
vascular endothelial cells (ECs) and smooth muscle cells through a paracrine signaling 
pathway in which ECs derived nitric oxide acts as the key signaling molecular 
messenger for vessel dilation. The underlying mechanism of ECs-SMCs interaction 
through NO will be thoroughly discussed in next chapter.  
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Figure 3.7 [A] Shows the representative expression of brain vascular α-smooth muscle 
actin (αSMA, red) in whole brain tissue sections (10 µm thick) in different experiment 
conditions with a significant increase by ethanol exposure (N=6 animals, 10~15 slices 
per animal). Scale bar: 30 μm. [B] Western blot analysis of αSMA levels in different 
experiment conditions. Data was analyzed by image J to obtain arbitrary densitometry 
intensity units. Three replicates were done for each animal per condition. Bar graphs 
show the quantified data that were expressed as ratio of αSMA immunoreactive bands 
to that of β-actin bands, with mean ±SEM. * indicates the statistical significance p<0.05 
compared with control or L-NAME+EtOH/L-NAME alone. 
 
3.3.5 Vessel Dilation Increases Waste Metabolite Clearance 
So far, we have shown that large size waste metabolites that are not able to diffuse across 
the subarachnoid (SA)-superior interface (due to the presence of SA microvilli) in CSF 
flow get accumulated in perivascular space in the presence of low dose alcohol. This 
includes the interstitial-perivascular movement of waste metabolites. The diffusion of 
these metabolites towards the perivascular space appeared to be regulated by alcohol 
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mediated increase in arterial vessel contraction and dilation. We then examined whether 
these accumulated waste metabolites at the perivascular space will diffuse into the 
perivenous space across the bed of capillaries, and get exchange/efflux into the blood 
circulation as clearance mechanisms. The results clearly showed an increase 
colocalization of the 2000 kDa FITC tracer and venule marker (endomucin) in alcohol 
group (Figure 3.8A – B) compared with controls (Figure 3.8C – D), even though the 
tracer aggregation in perivenous space was not as high as in perivascular space. This 
data suggests a limited exchange of metabolites from perivascular space to perivenous 
space, which indicates efflux of metabolites from perivascular/perivenous space into the 
blood circulation.   
This led us to examine validation of tracer in blood plasma samples from different 
experimental conditions as a proof-of-concept. Blood samples were collected at the time 
of sacrifice from different experimental groups with/without L-NAME injection, and 
separated the plasma. The 2000 kDa FITC tracer in blood plasma samples was detected 
by SpectraMax Multi-Mode fluorescence microplate reader at the specific excitation 
(490 nm) and emission (525 nm) wavelengths. We observed a significant increase of 
tracer fluorescence intensity in the plasma samples in low dose alcohol group compared 
with controls or the alcohol plus L-NAME group (Figure 3.8E), indicating that low dose 
alcohol promotes the waste metabolites clearance path from perivascular/perivenous 
space into the blood circulation. These findings suggest the existence of large size waste 
metabolites clearance path from perivascular or perivenous space into the blood 
circulation, which is regulated by alcohol-induced NO mediated cerebral vessel dilation.
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Figure 3.8 Validating the diffusive exchange of waste metabolite from perivascular to 
perivenous space (at the bed of capillaries). [A - D] Colocalization of FITC tracer 
(Green) and venule marker endomucin (red) in alcohol group (A&B) compared with 
control (C&D), indicating an exchange of large size metabolites from perivascular space 
to perivenous space. Scale bar: 30 μm.  [E] Detection of FITC-d2000 in blood plasma 
collected after 120 min cisterna magna injection from different experiment conditions, 
(n=6/per group, + SEM). One-way ANOVA and post-hoc turkey test (* p<0.05, 
compared with control) was performed to compare difference between each group. 
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3.4 Discussion 
We discuss the findings that large size waste metabolites in the brain that are unable to 
clear out by the conventional CSF clearance path get diffused towards perivascular-
perivenous space from the interstitial fluid and from the CSF-subarachnoid flow. Thus, 
there is a dynamic movement of large size waste metabolites from interstitial space and 
subarachnoid towards perivascular space under normal physiological condition.  To 
mimic those large size waste metabolites, we used a relative large molecular weight 
fluorescent tracer (2000 KD) and administered into brain. The rationale is that due to 
the molecular size limitation and also shown by other study [29], after injection into 
brain tracers tended to accumulate at perivascular space instead of being eliminated 
through typical clearance routes including BBB trans-vascular clearance, degradation 
and CSF/ISF diffusion as noted in publication [66]. This physiological behavior is 
comparable with what have been observed in certain neurological diseases including 
perivascular phosphorylated tau protein disposition in cerebral amyloid angiopathy 
(CAA) and aggregated amyloid beta protein in Alzheimer’s disease [75, 76]. To validate 
the use of tracers, we also showed that the tracers used in the study revealed similar 
movement pattern as A-β proteins following differnet injection routes (Figures D.1 and 
D.2). Thus, though differed from chemical composition, given the physiology similarity 
of tracers and large size waste metabolites in brain as discussed, the movement pattern 
of tracer was considered informative towards current study purpose. 
We firstly showed the perivascular disposition phenomenon by the bio-distribution 
of large size molecular weight fluorescent tracer injection from two different routes, a 
direct deposition of tracer into the CSF flow by intracisterna magna injection and a direct 
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deposit of tracer into interstitial space through intracranial cortical route. Even though 
the subarachnoid (SAS) was filled with fluorescence tracer within 30 min, the actual 
penetration of tracer into the perivascular space occurred after 60 minute in intracistertna 
magna injection (Figure 3.1A-F). In the interstitial cortical injection, the tracer diffused 
directly into perivascular space within 60 min (Figure 3.3A-D), while the CSF flow was 
filled with tracer at the much later time points (Figure 3.3E-F), indicating the slow 
clearance of large size waste metabolite from interstitial fluid to C3 choroid flexus. 
These data suggest that waste metabolites can diffuse directly into PVS time-
dependently from interstitial fluid and from CSF-subarachnoid flow, which is regulated 
by endothelial-smooth muscle cell dilation. Similar alternative clearance mechanisms of 
direct translocation of interstitial solutes to perivascular space have been proposed in 
mouse model [28].  
Intriguingly, the data showed that a very low level of 5.0 mM ethanol, equivalent 
of 0.02% blood alcohol level can enhance the dynamic movement pattern of these waste 
metabolites towards perivascular-perivenous space. This concentration is far below the 
legal limit of 0.08 % blood alcohol level. In spite of alcohol being an addictive 
substance, the low-dose of this legalized substance is likely to improve the clearance of 
waste metabolites in the brain. Thereby, one drink of alcohol a day may ameliorate the 
progression of many neurological diseases that are originated from toxicity of non-
clearance waste metabolites. Interestingly, a number of recent population-based cohort 
studies concluded that heavy alcohol use in chronic condition is associated with 
development dementia and progression of Alzheimer’s disease and cerebral amyloid 
angiopathy [77-84], the hallmark of these neurological diseases happen to be the 
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deposition of waste metabolites like A-β protein, or protein prion-like proteinopathies 
around the perivascular space [1, 2, 48]. These cohort studies also unequivocally noted 
the protective effects of low dose alcohol use against the progression of dementia and 
AD/CAA, with unknown mechanisms. It is apparent that beneficial or destructive effects 
of alcohol is dependent on the duration and concentration use. In the present studies, we 
use low level of alcohol to understand the protective mechanisms for promoting 
perivascular clearance because low-moderate alcohol use is protective of vascular and 
cardiovascular function [4, 64, 65, 85-87]. We also showed that use of alcohol 
concentrations that are between 2.5 mM - 20 mM (~ 0.08%) revealed comparable effects 
in terms of PVS clearance (Figure E.1).  The likely reason can be attributed to the 
findings that these alchol concentrations are adequately to stimulate eNOS expression 
and NO release (Figure E.2), which regulated the PVS clearance efficiency. In addition, 
repetitive intake of low dose alcohol (5 mM) showed similar effect (Figure E.3), which 
lined up with the beneficial effect of low dose alcohol intake.  
We noted here that the contrast effects of low dose alcohol intake and chronic use 
of high dose alcohol (equivalent of alcohol dependent subjects) in the context of blood-
brain barrier permeability and perivascular clearance path will be discussed in the 
following chapters.  
We then addressed the underlying clearance mechanisms of the accumulated waste 
metabolites from perivascular or perivenous space into the blood circulation by two 
approaches.  The exchange of waste metabolites from perivascular space to perivenous 
space across the bed of capillaries, and detection of waste metabolite in blood samples 
collected from jugular vein. Colocalization of tracer with venule marker clearly showed 
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a significant accumulation of tracer in perivenous space of alcohol group compared with 
controls (Figure 3.8A-D), however the tracer intensity was less than that of perivascular 
space (Figure 3.6A). These results indicated the movement of metabolites from 
perivascular to perivenous space across the bed of capillary. The exchange of waste 
metabolites from perivascular/perivenous space into the blood circulation as the 
clearance path was examined by the presence of fluorescent tracer in blood plasma 
samples from various experimental conditions. A significant detection of tracer in the 
plasma samples in low dose alcohol group was markedly higher than controls or alcohol 
plus NOS inhibitor L-NAME groups (Figure 3.8E). These data suggest that the tracer 
was leaked into the circulation from perivascular/perivenous exchange because this 
large size waste metabolite was not permeable from subarachnoid to sagittal sinuses due 
to blockade by subarachnoid microvilli. The significantly low level of tracer present in 
NOS inhibitor plus alcohol group also suggested the direct role of alcohol-induced NO 
elicited perivascular/perivenous-blood circulation clearance path. 
We then validated the underlying mechanisms that alcohol-elicited eNOS specific 
NO production promoted the cerebral arterial vessel dilation and clearance. The 
rationale was that NO production augmented the endothelial-smooth muscle cell 
reactive interactions and arterial vessel dilation. This is because low dose alcohol 
consumption led to an increase eNOS activity and NO production [4, 64, 65], whereas 
high dose chronic alcohol consumption led to detrimental consequences on vascular 
function [67, 88, 89]. In support of our hypothesis, we observed an increase reactivity 
of α-SMCs in low dose alcohol qualitatively and quantitative compared with controls or 
in the presence of NOS inhibitor (Figure 3.7A-B). The observations were in line with 
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the findings that NO-mediated endothelial-smooth muscle cells interaction was key to 
arterial vessel reactive dilation [90, 91], and perhaps the movement of tracer along PVS 
[73]. The rationale is that endothelial-derived NO generation can diffuse readily into the 
underlying SMCs and cause vessel dilation through a cascade of paracrine-mediated 
biochemical signaling events [90, 91], wherein NO serves as the key signaling molecule 
for vessel dilation. 
Apart from local level regulation of vessel dilation including response to 
mechanical forces (e.g., shear stress) and chemical stimuli (e.g., NO) as discussed above, 
it was also known that vessel contraction/dilation was neural activity dependent and 
increased vessel dilation was coupled sensory stimulus. For example, using whisker 
stimulation and cortical spreading depolarization, researchers observed microvascular 
diameter changes in smooth muscle covered microvessels in brain [63]. However, due 
to the study scope limitation, the current research focus was primarily on the local level 
regulation of regional blood vessel dilation that exerted by low dose alcohol. Brain 
activity dependent regulation was not discussed in this dissertation. 
In conclusion, the diffusive movement of large size waste metabolites from 
interstitial fluid and from CSF-subarachnoid flow into perivascular-perivenous drainage 
path is regulated by reactive dilation of endothelial-smooth muscle cells. We found that 
low dose alcohol can significantly promote these waste metabolites movement towards 
the perivascular-perivenous space and its clearance into the circulation. We confirmed 
that alcohol-elicited eNOS specific NO production regulated the cerebral arterial vessel 
dilation through endothelial-smooth muscle cell reactive interactions (Figure 3.9). The 
present findings are expected to have far-reaching translational significance, particularly 
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the timely clearance of entangled proteins in neurological diseases. 
 
 
Figure 3.9 Illustration of alcohol promotes waste metabolites clearance. (A) Arrows 
(orange) indicate the CSF subarachnoid flow and perivascular-perivenous clearance 
path (black) of large size waste metabolites (red dots) in neurodegenerative brain. Waste 
metabolites like β-amyloid proteins are aggregated more inside the interstitial space due 
to the lack of lymphatic system in the brain. Less metabolite are drained into the CSF 
flows due to less vessel dilative reactivity. (B) Neurodegenerative brain in the presence 
of low dose alcohol. Dilative arterial vessel reactivity promotes the dynamic movement 
of large size waste metabolites from interstitial fluid to perivascular space and from 
interstitial-CSF subarachnoid to perivascular space. Reactivity of endothelial and 
smooth muscle cells in arteries is mediated by alcohol-elicited eNOS activation and NO 
production. 
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CHAPTER 4 
MECHANISM OF ALCOHOL MEDIATED SMCs-ECs INTERACTION 
 
4.1 Summary 
We have shown that alcohol-mediated vasodilation can exert beneficial effects towards 
brain waste metabolites clearance through induction of endothelial function and 
enhancement of neighboring smooth muscle reactivity from previous chpater. Here in 
this chapter, we further investigated the underlying mechanism of ECs-SMCs 
interaction by addressing the response of endothelial cells to low dose alcohol and 
examining level of NO releasing and corresponding enzymes expression. We 
determined the activities of surrounding smooth muscle cells by evaluating the 
phosphorylation status of myosin light chain (MLC) and activities of corresponding 
regulatory subunits. Results indicated that low level alcohol promotes NO release from 
endothelial cells through eNOS. NO induced smooth muscle relaxation occured through 
myosin light chain dephosphorylation. Regulation of NO-mediated MLC 
dephosphorylation was done via the paradigm shift from myosin light chain kinase to 
myosin phosphatase activities. We validated such observations by qualitative 
immunostaining and quantitative Western blot analyses. Collectively, we showed that 
alcohol induced arterial vessel dilation was via eNOS mediated NO generation in ECs, 
which rapidly diffused into neighboring SMCs and caused MLC dephosphorylation 
through interplay of myosin light chain kinase and myosin phosphatase activities. 
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4.2 Background 
Low-to-moderate consumption of alcohol is known to exert protective effect towards 
biological vascular system. Intriguingly, consistent epidemiologic evidence has pointed 
to an inversely association between moderate alcohol consumption and vascular disease 
[86, 87, 92]. For example, human studies revealed a 20 – 40 % reduction of 
cardiovascular disease among drinkers of alcoholic beverages compared with non-
drinkers [93]. However, the underlying mechanism of such effect is still under debate.  
Some researchers claimed that beverage choice among wine, beer and liquor may 
bear more relevance and they supported a preferential red wine protective effect that 
partly attributes to the polyphenolic antioxidant content [94]. This hypothesis was 
initiated by a report known as the ‘French Paradox’ that describes the low vascular 
disease and mortality ratio of the French population despite their high dietary intake of 
saturated fats, a phenomenon accredited to consumption of red wine due to its active 
composites, including  resveratrol and other polyphenolic agents [95-97]. To support 
this point of view, several animal studies have focused on polyphenol vascular effects 
and revealed that wine polyphenols showed antioxidant, anti-inflammatory, hypotensive 
and anti-platelet aggregation actions [98-101]. In a human study, researchers showed 
that intaking of dealcoholized red wine at 1-week intervals significantly increased 
plasma antioxidants, indicating the strong antioxidant potential of wine polyphenols 
[102].  
On the contrary, other studies showed that equal effects of alcohol beverage were 
observed on vascular disease risk and the content of ethanol and its subsequent 
metabolites acted as active protective agents [103].  For example, alcohol is known to 
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elicit nitic oxide (NO) generation in vivo through vascular endothelial function [74]. 
Researchers found that low dose alcohol improved vascular endothelial function through 
increasing endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) 
production [74]. Loading low dose alcohol to certain cell types (e.g., human umbilical 
vein endothelial cells, bovine aortic endothelial cells) promoted NO production, eNOS 
protein expression [64, 104, 105] and corresponding mRNAs expression [65]. Similar 
phenomenon was observed in animal studies in which low dose ethanol consumption in 
rats increased nitric oxide production and eNOS expression in the aortic vascular wall 
[106].  Taken that NO can serve as a signaling molecule that regulates vascular dilative 
activity, studies have shown that low dose alcohol exertes a protective effect towards 
vasculatures through NO mediated vessels dilation. In vivo, animal studies have shown 
that acute low dose EtOH increases release of NO, augments endothelium-mediated 
vasodilatation [106-108] and decreases mean blood pressure [106]. In a human 
multiethnic study, drinkers (between 1 drink/month and 2 drinks/day) were more likely 
to have a higher flow-mediated dilation (FMD) than non-drinkers and those who drank 
>2 drinks/day, independently of the type of alcoholic beverage consumed [109].  
In a previous study [62], we showed that low dose alcohol-elicited NO production 
promoted large size brain waste metabolites clearance by enhancing interaction of 
vascular endothelial cells (EC) and smooth muscle cells (SMC). But the mechanism 
underlying ECs-SMCs interactive cross-talk was not yet fully understood yet. Here, we 
investigated the idea that alcohol-elicited NO from ECs can immediately diffuse into 
neighboring SMCs, subsequently cause relaxation of myosin light chain (MLC) in SMC, 
and ultimately induce vasodilation. The rationale is that the contractility of smooth 
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muscle cell is controlled by a cellular component known as myosin light chain (MLC) 
and NO has been shown to actively engage in regulation of MLC regulatory subunits 
[110]. 
4.3 Results 
In this chapter, we examined the idea that low dose alcohol mediated arterial vessel 
dilation was done through interaction of vascular ECs and SMCs whereby NO generated 
from ECs rapidly diffused into neighboring SMCs and subsequently caused SMC 
relaxation. To verify this idea, we firstly determined the response of ECs to low dose 
alcohol by examining NO generation and enzyme expression. Then we investigated how 
SMCs react to NO focusing on myosin light chain phosphorylation level and 
corresponding enzymes activities. The underlying mechanism of alcohol mediated 
arterial vessel dilation was supported by these findings. 
4.3.1 Alcohol below 20 mM Has no Toxic Effect on ECs and SMCs  
We first focused on the toxicity effect of different alcohol concentration on the co-
culture system of two cell types: ECs and SMCs. The two cell types were mixed at 1:1 
ratio and directly in contact with each other to mimic in vivo vascular structures. 
Corresponding cellular protein markers (vWF for ECs and SMA for SMCs) were 
evaluated to verify the co-existence (Figure 4.1A and B). A Serial concentration of 
alcohol was used to determine the toxicity as shown in the graph. Noted that the highest 
dose I used was 20 mM, which is approximately equivalent to the legalized blood 
alcohol level (~0.08%). I found that after incubating with alcohol at given concentrations 
for 2 hrs, no significant cell survival difference was observed among alcohol treatments 
compared with control (Figure 4.1C), indicating that alcohol concentration less than 20 
65 
 
mM have no toxic effect on ECs and SMCs, which is consistent with previous report 
[72].  
 
 
Figure 4.1 Cell toxicity evaluation. Various doses of alcohol were loaded to endothelial 
– smooth muscle cells co-culture system. Two hours were given before proceeding to 
MTT assay.  [A and B]. Immunoreactive bands of vWF (endothelial cell markers), SMA 
(smooth muscle cell markers) and β-actin, and quantitative corresponding protein 
content in different experimental groups. Results were expressed as the ratio of protein 
of interest to that of actin bands and presented as mean values (± SEM). [C]. Cell toxicity 
assay by MTT showed viability with variable concentrations of alcohol represented by 
plot. Results were expressed as the ratio of OD value of each experimental condition to 
that of control and presented as mean values (± SEM). *Statistically significant (p < 
0.05) compared with controls. Three replicates were done for each sample from at least 
N=3 cultures. 
 
4.3.2 Alcohol Promotes NO Release from ECs through eNOS not iNOS 
Next, we proceeded to investigate the response of ECs to alcohol (10 mM). The optimal 
alcohol concentration was determined from a dose-dependent study. We analyzed the 
real-time NO production in ECs by Free Radical Analyzer using a micro-sensor detector 
and found that alcohol exposure significantly elevated release of NO in ECs compared 
with baseline (Figure 4.2A and B). Moreover, we observed a time-dependent increase 
of NO production by checking different time intervals. This can be justified by the fact 
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that NO generation depends on corresponding enzymes induction. 
 
 
Figure 4.2 Real-time NO production in cultured endothelial cells in the presence of 10 
mM EtOH. 50 µM L-NAME pre-treated tissue for 30 min as baseline. Medium 
containing 10 mM EtOH was supplied subsequently. [A]. Functional output from free 
radical analyzer. Graph denotes the current signal (pA) change (proportional to NO 
concentration) captured by the NO sensor during each data collection interval, which 
was marked by blue vertical lines.  [B]. Bar graph was plotted as the ratio of signal 
readout of each acquisition interval to that of baseline and presented as mean values (± 
SEM). Statistically significant (*p < 0.05, ***p<0.001) compared with controls. Three 
replicates were done for each sample from at least N=3 cultures. 
 
We then evaluated the induction of NO generation enzymes, eNOS and iNOS to 
correlate with NO release. Interestingly, immunostaining revealed a huge increase of 
eNOS induced by alcohol and not surprisingly the effect was neutralized by inhibitor 
(L-NAME) (Figure 4.3A), which was further validated by significant elevation of eNOS 
levels by ethanol compared with control (p<0.05), as determined by Western blot 
analyses (Figure 4.3B). On the contrary, no significant change of iNOS was found in 
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alcohol group compared with control by both immunostaining and western blot (Figure 
4.4A and B), indicating that NO release can be mainly accredited to eNOS but not iNOS. 
This can be explained by the idea that elevation of physiological NO levels in endothelial 
cells through eNOS augments vascular function whereas iNOS mediates massive NO 
production associated with free radical generation, which exerts detrimental effect 
towards surrounding tissues [72, 111]. Further examination of nitrosative stress marker, 
3-nitrotyrosine (3-NT) expression across groups showed no significant difference 
(Figure 4.5A and B), supporting this justification.  
 
 
Figure 4.3 EtOH induces eNOS protein expression in endothelial cells. [A]. 
Immunostaining of eNOS (green) and vWF (red) protein in control, EtOH (10 mM), L-
NAME + EtOH and L-NAME. eNOS and vWF were used as primary antibodies 
(information in Table 2.1). Alexa Fluor 488/594 were used as corresponding secondary 
antibodies. Data representats at least N=3 cultures per each group. Scale bar: 30 μm. 
[B]. Immunoreactive bands of eNOS and β-actin, and quantitative corresponding protein 
content among experimental groups. Results were expressed as the ratio of protein of 
interest to that of actin bands and presented as mean values (± SEM). *Statistically 
significant (p < 0.05) compared with controls. Three replicates were done for each 
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sample from at least N=3 cultures. 
 
 
 
Figure 4.4 No difference of iNOS protein expression in endothelial cells under different 
experimental conditions. [A]. Immunostaining of iNOS (green) and vWF (red) protein 
in control, EtOH (10 mM), L-NAME + EtOH and L-NAME. iNOS and vWF were used 
as primary antibodies (information in Table 2.1). Alexa Fluor 488/594 were used as 
corresponding secondary antibodies. Data represents at least N=3 cultures per each 
group. Scale bar: 30 μm. [B]. Immunoreactive bands of iNOS and β-actin, and 
quantitative corresponding protein content among experimental groups. Results were 
expressed as the ratio of protein of interest to that of actin bands and presented as mean 
values (± SEM). No statistically significant (p < 0.05) difference compared with 
controls. Three replicates were done for each sample from at least N=3 cultures. 
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Figure 4.5 No difference of nitrosative marker, 3-nitrotyrosine expression in endothelial 
cells under different experimental conditions. [A]. Immunostaining of 3-NT (green) and 
vWF (red) protein in control, EtOH (10 mM), L-NAME + EtOH and L-NAME. 3-NT 
and vWF were used as primary antibodies (information in Table 2.1). Alexa Fluor 
488/594 were used as corresponding secondary antibodies. Data was representation of 
at least N=3 cultures per each group. Scale bar: 30 μm. [B]. Immunoreactive bands of 
3-NT and β-actin, and quantitative corresponding protein content among experimental 
groups. Results were expressed as the ratio of protein of interest to that of actin bands 
and presented as mean values (± SEM). No statistically significant (p < 0.05) difference 
compared with controls. Three replicates were done for each sample from at least N=3 
cultures. 
 
4.3.3 NO by Donor SNAP (15 µM ) Not Induces Free Radical Damage in SMCs 
To precisely investigate the effect of NO on SMCs, we also exposed cells directly to NO 
through the NO donor, SNAP (S-nitroso-N-acetylpenicillamine). NO is a highly active 
molecule that in the presence of O2, can react with O2− to form peroxynitrite (ONOO−), 
a potent oxidizing agent that can lead to cytotoxicity by nitrating and hydroxylating 
aromatic compounds, including guanosine and tyrosine (nitrotyrosine) [74, 112]. To 
avoid such deleterious effects, we tried to limit the amount of NO using but still 
adequately for experimental purposes. Therefore, we conducted a dose-dependent assay 
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(10 – 100 µM) and found that concentrations less than 20 µM did not induce noticeable 
nitrosative stress on SMCs, which agrees with a previous paper [72]. Among all 
concentrations, we found that 15 µM yielded best results for NO supply (Figure 4.6A 
and B) without significant free radicals damage (Figure 4.7A and B) and thus, was 
determined as the working dose.  
 
 
Figure 4.6  Real-time NO level in cultured SMCs in the presence of 15 µM SNAP.  
Cells were pre-treated with 50 µM L-NAME for 30 min as baseline. Medium containing 
15 µM SNAP was supplied subsequently. [A]. Functional output from free radical 
analyzer. Graph denotes the current signal (pA) change (proportional to NO 
concentration) captured by the NO sensor during each data collection interval, which 
was marked by blue vertical lines.  [B]. Bar graph was plotted as the ratio of signal 
readout of each acquisition interval to that of baseline and presented as mean values (± 
SEM). Statistically significant (*p < 0.05, ***p<0.001) compared with controls. Three 
replicates were done for each sample from at least N=3 cultures.  
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Figure 4.7 Nitrosative marker, 3-nitrotyrosine expression in cultured SMCs in the 
presence of 15 µM SNAP. [A]. Immunostaining of 3-NT (green) and SMA (red) protein 
in control and SNAP (15 µM SNAP). 3-NT and SMA were used as primary antibodies 
(information in Table 2.1). Alexa Fluor 488/594 were used as corresponding secondary 
antibodies. Data represents at least N=3 cultures per each group. Scale bar: 300 μm. [B]. 
Immunoreactive bands of 3-NT and β-actin, and quantitative corresponding protein 
content among experimental groups. Results were expressed as the ratio of protein of 
interest to that of actin bands and presented as mean values (± SEM). Statistically 
significant (p < 0.05) compared with controls showed no difference. Three replicates 
were done for each sample from at least N=3 cultures. 
 
4.3.4 Alcohol Induced Smooth Muscle Relaxation Was through Myosin Light 
Chain Dephosphorylation  
 
Next, we evaluated the mechanism of alcohol-elicited-NO from ECs induced smooth 
muscle relaxation by checking phosphorylation levels of myosin light chain (MLC). The 
phosphorylation of the 20-kDa myosin regulatory light chains (MLC) is the primary 
determinant of cross-bridge attachment and cycling during contraction and relaxation in 
smooth muscle [113]. In brief, phosphorylation of MLC leads to SMC contraction while 
dephosphorylation yields relaxation. Using specific antibodies that can detect 
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phosphorylation of MLC at Ser19/20 in smooth muscle cells, we found that compared 
with control, alcohol-induced-NO from ECs significantly diminished phosphorylation 
levels of MLC at Ser19/20 in SMCs and, in parallel quantitative assay western blot 
validated this finding (Figure 4.8A and B). The positive control from NO (SNAP) 
supported this finding. Since dephosphorylation of MLC suggests relaxation of SMC, 
the data indicates that alcohol-induced-NO-caused SMC relaxation was through 
dephosphorylation of MLC at Ser19/20.  
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Figure 4.8 Phospho-myosin light chain (Ser19/20) level in cultured ECs-SMCs in the 
presence of 10 mM EtOH and15 µM SNAP. [A and B]. Immunostaining of SMA (green) 
and phosphor-MLC protein in control, low dose alcohol and SNAP (15 µM; NO donor 
as positive control). SMA and smooth muscle specific phosphor-MLC(Ser19/20) were 
used as primary antibodies (information in Table 2.1). Alexa Fluor 488/594 were used 
as corresponding secondary antibodies. Data represents at least N=3 cultures per each 
group. Scale bar: 200 μm. [B]. Immunoreactive bands of phosphor-MLC (Ser20) and β-
actin, and quantitative corresponding protein content among experimental groups. 
Results were expressed as the ratio of protein of interest to that of actin bands and 
presented as mean values (± SEM). *Statistically significant (p < 0.05) compared with 
controls. Three replicates were done for each sample from at least N=3 cultures. 
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4.3.5 Alcohol Induced MLC Dephosphorylation Was via Myosin Phosphatase 
Activities 
 
Further, we proceeded to investigate the underlying mechanism of alcohol-elicited-NO 
mediated MLC dephosphorylation in the co-culture system. MLC phosphorylation level 
was determined by the balance of the Ca2+ dependent myosin light chain kinase 
(MLCK) and myosin light chain phosphatase (MLCP) activities. When MLCK was 
activated by Ca2+ -calmodulin complex, it underwent posttranslational change, 
phosphorylation to become active [114]. Whereas its counterpart, MLCP activity was 
similarly regulated by phosphorylation mediated events but in a more complex way. 
According to recent publications, phosphorylation of the MLCP regulation subunit, 
myosin phosphatase target subunit 1 (MYPT1) at Ser618/668/692/695 residues can 
increase MLCP activities while at Thr696/853 residues, led to inhibitory effects [110, 
115, 116]. Thus, by employing antibodies that target specific phosphorylation residues 
pertinent to each protein, we examined the activities of MLCK and MLCP in SMCs 
under control, alcohol and SNAP (positive control) treatment. Interestingly, we found 
that the phosphorylation level of MYPT1 at Ser618/668 in SMCs was significantly 
increased by alcohol and NO (positive control) through immunostaining and western 
blot (Figure 4.9A and B) assays, indicating that MLCP activities in SMCs were up-
regulated by alcohol-induced-NO from ECs. Meanwhile, the level of phospho-MLCK 
at Ser 1760 was decreased under alcohol and NO treatment compared with control 
(Figure 4.9C), suggesting a reduction of MLCK activities by alcohol-induced-NO from 
ECs. Postitive control validated the role of NO in this process.  
Collectively, the information that this data conveys is that alcohol-elicited-NO 
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release from ECs is strongly correlated with MLCP/MLCK activities in SMCs: NO led 
to elevation of MLCP activity but inhibition MLCK. When the entire system favored 
more MLCP, MLC turned to be dephosphorylated and SMC manifested relaxation.    
 
 
Figure 4.9 Phospho-MYPT1/2 (Ser618/688) and phosphor-MYLK (Ser1760) level in 
cultured ECs-SMCs in the presence of 10 mM EtOH and 15 µM SNAP. [A]. 
Immunostaining of SMA (green) and phospho-MYPT1/2 (Ser618/688) (red) protein in 
control, EtOH and SNAP (15 µM SNAP). SMA and phospho-MYPT1/2 (Ser618/688) 
were used as primary antibodies (information in Table 2.1). Alexa Fluor 488/594 were 
used as corresponding secondary antibodies. Data was representation of at least N=3 
cultures per each group. Scale bar: 200 μm. [B and C]. Immunoreactive bands of [B]: 
phospho-MYPT1/2 (Ser618/688), [C]: phosphor-MYLK (Ser1760) and β-actin, and 
quantitative corresponding protein content among experimental groups. Results were 
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expressed as the ratio of protein of interest to that of actin bands and presented as mean 
values (± SEM). *Statistically significant (p < 0.05) compared with controls. Three 
replicates were done for each sample from at least N=3 cultures. 
 
4.4 Discussion 
In the present study, we discuss the finding that alcohol, especially at low dose ingestion, 
can promote arterial vessel dilation through enhancing interaction of vascular 
endothelial cells and smooth muscle cells. Firstly, we evaluated the response of ECs 
when exposed to low dose alcohol (10 mM) with focus on nitric oxide (NO) generation 
and corresponding enzymes expression. We showed that alcohol, at given doses, can 
increase NO releasing, which is mediated by elevation of eNOS expression instead of 
iNOS. This phenomenon was consistent with previous observation in animal studies 
[62] and can be justified by the difference between those two isomers in terms of NO 
generation: eNOS augments physiological NO levels in endothelial cells that regulate 
normal vascular function while iNOS is typically associated with free radical generation 
like peroxynitrite, inducing surrounding tissue damage [72, 111]. Further evidence of 
no over-expression of the nitrosative stress marker among groups (Figures 4.5A and B) 
validates this explanation. 
We then investigated the underlying mechanism of alcohol-elicited NO-mediated 
relaxation of SMCs. Researches have shown that NO, known as an endothelium-
mediated vessel dilator, can regulate neighboring smooth muscle contractility [106-
108]. Smooth muscle cells, unlike skeletal and cardiac muscles, relied on 
phosphorylation of the 20 KDa regulatory myosin light chain (MLC) at the Ser19 
residue to exert contractile activities [110]. The regulation of phosphorylation extent 
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was determined by the balance of the activities of two protein enzymes: myosin light 
chain kinase (MLCK) and myosin light chain phosphatase (MLCP) [115]. We showed 
that by treating cultured ECs-SMCs with alcohol and NO (positive control), the 
phosphorylation level of MLC was significantly diminished compared with control and 
that MLCP activities line up with MLC dephosphorylation levels whereas MLCK 
activities are adversely correlated (Figures 4.8 and 4.9), indicating that alcohol-elicited 
NO-caused SMCs relaxation was regulated by MLCP/MLCK mediated MLC 
phosphorylation.  
NO can activate soluble guanylate cyclase, thus augmenting cGMP. Elevated 
cGMP presumably activates cGMP-dependent protein kinase (PKG) and hence induces 
a variety of phosphorylation events. For instance, the phosphorylation of several 
intracellular mechanisms by PKG results in a reduction in myoplasmic calcium [114, 
117], which reduces engagement of calcium with calmodulin. Since formation of the 
Calcium-Calmodulin complex is essential for MLCK activation, a reduction of proper 
engagement will inevitably lead to decreasing MLCK activities and therefore 
dephosphorylate MLC. Also, cGMP-PKG was found to directly involve in MLCP 
regulation in several studies. For example, phosphorylation of Ser-695 at myosin 
phosphatase target subunit 1 (MYPT1) by cGMP mediated PKG was found to activate 
MLCP [110] and inhibition of NO mediated cGMP-PKG by NOS inhibitor (L-NAME) 
showed a reduction of phosphorylation at S695/S668, which correlated with decreasing 
MLCP activities [116].  
Intriguingly, previously we reported that a very low level of 5.0 mM ethanol, 
equivalent of 0.02% blood alcohol level, can enhance the dynamic movement pattern of 
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large size waste metabolites towards the perivascular-perivenous space and the 
underling mechanism was that alcohol-elicited eNOS specific NO production regulated 
the cerebral arterial vessel dilation through endothelial-smooth muscle cell reactive 
interactions [62]. The current research further addressed the mechanism we proposed 
previously: alcohol induced arterial vessel dilation is via eNOS mediated NO generation 
in ECs, which rapidly diffuse into neighboring SMCs and cause MLC 
dephosphorylation through an interplay of myosin light chain kinase and myosin 
phosphatase activity (Figure 4.10) 
 
 
Figure 4.10 Schematic representation of alcohol mediated endothelial cells and smooth 
muscle cells interaction. Alcohol can elicit eNOS expression and NO production in 
endothelial cells. NO from endothelial cells rapidly diffuses into surrounding SMCs, 
causing elevation of cGMP. cGMP mediated PKG pathway leads to myosin light chain 
relax (de-phosphorylation) through: 1). up-regulation of myosin light chain phosphatase 
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activities;  2) down-regulation of myosin light chain kinase activities.   
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CHAPTER 5 
CONTRAST EFFECTS OF LOW/ACUTE AND MODERATE/CHRONIC 
ALCOHOL ON CNS WASTE METABOLITES CLEARANCE 
 
In previous chapters, we have shown that low dose alcohol promotes perivascular 
clearance of waste metabolites in the brain, which is regulated by dilative reactivity of 
arterial smooth muscle cells and endothelial cells via the signaling molecule, NO. These 
findings clearly indicate the importance of blood-brain barrier (BBB) transvascular 
clearance of large size metabolites in the CNS, where the lymphatic clearance system is 
absent. In this chapter, we examined the contrast effects of acute low dose and chronic 
moderate alcohol intake on perivascular clearance of waste metabolites in the brain. 
 
5.1 Summary 
To evaluate the contrast effects of acute low dose and chronic moderate alcohol intake 
on waste metabolites clearance in the brain, we injected a large size fluorescent dye 
representing waste metabolites like A-β protein into the cerebrospinal fluid (CSF). Then, 
we examined the bio-distribution of tracer towards perivascular space in different brain 
regions by whole brain tissue section scanning. We found that the underlying molecular 
and cellular mechanisms that drive the increase or decrease movement of tracer to 
perivascular space by acute/chronic alcohol exposure correlated to BBB integrity and 
arterial vessel reactivity. Accordingly, the contrast effects of alcohol appear to be 
regulated by the switch mechanisms of endothelial specific nitric oxide synthase (eNOS) 
activation by low dose and inducible NOS (iNOS) by moderately high alcohol exposure 
in chronic conditions. We validated these observations by qualitative and quantitative 
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data. As such, my conlusion is that low dose alcohol promotes the diffusive movement 
of waste metabolites to perivascular clearance through eNOS-derived NO-regulated 
arterial endothelial-smooth muscle cells dilative reactivity without affecting the integrity 
of BBB. Whereas, continuous induction of iNOS in chronic alcohol exposure causes 
oxidative damage of the arterial endothelial-smooth muscle layers that led to BBB 
dysfunction, reducing dilative reactivity, and decreasing movement of waste metabolites 
from interstitial space/CSF to the perivascular-perivenous drainage path.  
 
5.2 Background 
Effect of alcohol consumption and metabolism on vascular tissues yields biphasic 
consequences that depend on drinking patterns: low alcohol intake leads to beneficial 
effects while high amount of ingestion delivers detrimental results. Researchers found 
that low dose alcohol improved vascular endothelial function through increased 
endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) production 
[74]. For example, loading low dose alcohol to various cell types (e.g., human umbilical 
vein endothelial cells, bovine aortic endothelial cells) elicited NO production, eNOS 
protein expression [64, 104, 105] and corresponding mRNA expression [65]. A similar 
phenomenon was observed in animal studies: low dose ethanol consumption in rats 
increased nitric oxide production and eNOS expression in the aortic vascular wall [106].  
Given that NO is known as an endothelium-mediated vessel dilator that regulates 
vascular contractility, investigators found that low dose alcohol can exert a protective 
effect towards vasculatures due to NO mediated vessels dilation. In vivo animal studies 
showed that acute low dose EtOH intake increased release of NO, augmented 
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endothelium-mediated vasodilatation [106-108] and decreased mean blood pressure 
[106]. In a human multiethnic study, drinkers (between 1 drink/month and 2 drinks/day) 
were more likely to have a higher flow-mediated dilation (FMD) than non-drinkers and 
those who drank >2 drinks/day, independent of the type of alcoholic beverage consumed 
[109], indicating beneficial vascular effects gained from low dose alcohol.   
On the contrary, moderate/chronic alcohol consumption assumed an opposite 
effect. For example, in a thoracic aorta isolated from chronic ethanol-fed rats, eNOS 
expression and NO levels were down-regulated, leading to diminished vasorelaxation 
[118]. In other studies, researchers observed that dilatation of rat basilar arteries or pial 
arterioles was less in alcohol fed rats compared with non-alcohol-fed rats; while 
superoxide dismutase and NAD(P)H oxidase inhibitor apocynin were able to ameliorate 
the loss of function, suggesting that ROS induced by chronic alcohol may lead to 
impaired eNOS-mediated vasodilation [119, 120]. In addition to what was described 
above, alcohol-induced oxidative/nitrosative stress was known to cause vascular 
damage. Alcohol-induced tissue injury was mediated via metabolism of ethanol by 
alcohol dehydrogenase and cytochrome P450 2E1 that produced acetaldehyde and 
reactive oxygen species/reactive nitrogen species (ROS/RNS) [111, 121]. Thus, tissue 
injury was supposed to occur in cell types that expressed ethanol metabolizing or radical 
generating enzymes, like inducible nitric oxide synthase (iNOS) [72, 122]. For example, 
it is widely known that the blood-brain barrier (brain microvessels) is vulnerable to 
alcohol-induced free radical damage. Haorah et al. revealed that alcohol metabolizing 
enzymes have been shown to localize in the brain microvessel endothelium [111, 123, 
124] and metabolism of alcohol in brain endothelium generates oxidative and nitrosative 
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products that cause free radical damage to brain microvessels including the BBB [72, 
111].  
In previous findings [62], we described that alcohol promotes waste clearance in 
the CNS via brain vascular reactivity. It is known that waste metabolites can be drained 
out of the brain through various clearance systems, including enzymatic degradation, 
cellular uptake, transport across the blood–brain barrier (BBB), and interstitial fluid 
(ISF)/cerebrospinal fluid (CSF) absorption into the circulatory and lymphatic systems. 
Out of those clearance routes, BBB trans-vascular clearance from brain to blood 
provides functionally a major pathway for elimination of different waste metabolic 
products from brain and accounts for > 80% of clearance of amyloid-beta physiological 
conditions [59-61, 66]. However, large size waste metabolites like tauopathy, prion-like 
proteinopathies, cerebral amyloid angiopathy, and Aβ proteins are seen accumulated 
around the perivascular space in brain tissue from neurological diseases [1, 2, 48], 
suggesting that large size waste metabolites are not cleared by CSF, glymphatic, or 
meningeal lymphatic systems. We found that dynamic movement of large size waste 
metabolites from interstitial space and subarachnoid towards perivascular space is 
enhanced when interaction of brain vascular endothelial cells (ECs) and smooth muscle 
cells (SMCs) is prompted [62]. Interestingly, low dose alcohol (5 mM) can facilitate this 
process through up-regulation of NO since alcohol especially low dose was known to 
increase eNOS expression [64, 65, 74, 104]. We showed that clearance of large size 
waste metabolites was increased by low dose alcohol while NOS inhibitor neutralized 
this effect, indicating the underlying mechanism of alcohol-elicited eNOS activation and 
NO production [62]. 
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However, the pendulum shifts when it comes to chronic alcohol intake. 
Epidemiological population-based cohort studies revealed that heavy alcohol use in 
chronic condition was associated with development dementia and progression of 
Alzheimer’s disease and cerebral amyloid angiopathy [5, 77, 80, 81, 83, 84, 125, 126], 
the hallmark of these neurological diseases happen to be the deposition of waste 
metabolites like Aβ protein, or protein prion-like proteinopathies around the 
perivascular space [1, 2, 48]. These cohort studies also unequivocally noted the 
protective effects of low dose alcohol use against the progression of dementia and 
AD/CAA, with unknown mechanisms. Thus, it is apparent that the beneficial or 
destructive effects of alcohol depend on the duration and concentration used.  
In conclusion, we hypothesize the contrast effect of low dose and 
chronic/moderate alcohol on brain waste metabolites clearance: low dose facilitates 
clearance by acting as a vasodilator through activating eNOS and enhancing brain 
vascular endothelial cells (ECs)-smooth muscle cells (SMCs) interaction, while 
chronic/moderate condition hampers the clearance due to iNOS/free radicals mediated 
impairment of ECs-SMCs interaction. The rationale is that activation of eNOS by low 
concentrations of ethanol elevates physiological NO levels and augments ECs-SMCs 
interactive reactivity whereas chronic/moderate causes free radical damage to 
microvessels and leads to BBB dysfunction, reducing vascular dilative reactivities and 
decreasing perivascular clearance.   
 
5.3 Results 
We investigated the contrast effects of low/acute and moderate/chronic alcohol on brain 
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waste metabolites clearance in this study. Here, we first focused on bio-distribution of 
2000 kDa fluorescent dye representing large size waste metabolites in three different 
experimental conditions: control, low/acute alcohol (5 mM) and moderate/chronic 
alcohol. Low dose was found to promote dynamic movement of tracers along the 
perivascular space (PVS) while moderate/chronic showed an opposite effect. Further 
examination revealed that low dose alcohol elicited eNOS activation and improved ECs-
SMCs interactive reactivity whereas chronic/moderate alcohol induced iNOS 
expression that led to tissue damage at brain vasculatures including endothelium, smooth 
muscle cells and blood-brain barrier (BBB) tight junction proteins, indicating that 
chronic/moderate alcohol decreased vascular dilative reactivities and exerted 
detrimental effect towards brain PVS clearance. 
5.3.1 Animal Model of Liquid-Diet Alcohol Intake 
To determine success of the pair-feeding procedure, we weighed and recorded rats’ 
weight on a weekly basis. At the time of sacrifice (12 weeks), the average body weight 
was 428 ± 11.1 for pair-fed control and 451 ± 10.2 for pair-fed alcohol. This was 
consistent with previous reports that pair-fed alcohol revealed overall higher body 
weight distribution at the end of the feeding cycle compared with control [16]. Weekly 
body weight record showed that at early feeding cycles, alcohol feeding showed lower 
weight-gaining compared with control. That was because by nature animals required 
enough time to acclimate to the taste of alcohol. Once accustomed (after week 4), 
weight-gaining rate of alcohol rats exceeded that of control and weight of alcohol rats 
started to approach and preceded control (after week 6).  
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Table 5.1 Pair-feeding Rat Body Weight and Blood Alcohol Concentration Statistics 
before Sacrifice (12 weeks after feeding) 
 
 
 
Prior to sacrificing, blood alcohol concentrations for all rats was determined to be 
9.1 – 28.8 mmol/L in alcohol diet ingested animals (Table 5.1), which was consistent 
with our previous results [127]. The huge variation in blood alcohol levels is common 
in animal studies due to nocturnal feeding habits of rats and variation in ethanol 
metabolic and clearance rate.  
5.3.2 Injection of FITC-d2000 into C3 Region of CSF Flow under Control, Low 
Dose Alcohol and Chronic Alcohol Conditions  
 
To evaluate the contrast effects of low/acute and moderate/chronic alcohol on dynamic 
movement and clearance of large size waste metabolites in the brain, we injected FITC-
d2000 (MW: 2000 KD) directly into the CSF flow via cisterna magna. We then 
evaluated the bio-distribution of tracer in the brain two hours after injection under 
different experimental conditions. We observed that low/acute alcohol enhanced tracer 
movement along vasculatures whereas moderate/chronic hampered this process. For 
example, in the low/acute study, more tracers were found at the perivascular spaces 
(PVS) compared with control, which was in accordance with previous finding [62]. 
 
Body weight (g) after 12 weeks pair-fed (n=15 pairs) Blood alcohol 
concentration (mM) 
Gro
up 
Mean Standard 
Deviation 
Median Min Max Mean Range 
Cont
rol 
428 11.1 429 399 449 0.002 0 – 0.005 
EtO
H 
451 10.2 451 437 468 15.6 9.1 – 28.8 
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However, opposite effect revealed under the moderate/chronic treatment.  We barely 
found any tracers at PVS two hours after injection in moderate/chronic condition, 
suggesting that dynamic movement of tracers was decreased (Figure 5.1 Top A-I). This 
qualitative data was further validated by quantification of arbitrary fluorescence 
intensity at PVS (Figure 5.1 Bottom A, *** p<0.001).  
In addition, to evaluate the clearance efficiency, we also examined fluorescence 
intensity in systematic blood plasma collected from the jugular vein 2 hours after 
injection. Data (Figure 5.1 Bottom B) suggested that clearance from inside the brain to 
circulation was significantly (*** p<0.001) decreased in the chronic alcohol group 
compare with control, which was in parrel with the PVS tracer movement results. 
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Top: 
 
Figure 5.1 Tracer bio-distribution in the rat brain under different experiment conditions. 
Tracers were injected into the rats brain through cisterna magna and 2 hours were given 
before sacrificing. Coronary brain slices (45 µm) mounted with Dapi on glass slides 
were used for imaging.  Top: [A, B and C]. Bio-distribution of CSF tracer (FITC-d2000, 
green) in control, EtOH (low dose alcohol) and chronic alcohol groups. Scale bar: 1 mm. 
[D-I]:  Detail of corresponding boxed areas from A, B and C. Scale bar: 25 μm. Data 
was representation of at least N=6 animals per each group.  
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Bottom:  
 
Figure 5.1 Bottom: [A]. Fluorescence intensity quantification of tracer biodistribution 
at the PVS was calculated as mean fluorescence intensity on each slide (from N=6 
animals, 10~15 slices were taken from each animal, +SEM) and presented as bar graphs. 
Statistically significant (***p < 0.001) compared with controls. Three replicates were 
done for each animal sample from at least N=6 animals. [B]. Blood plasma tracer 
fluorescence intensity quantification. Samples were from N=6 animal per each group. 
Statistically significant (***p < 0.001) compared with controls.   
 
5.3.3 Contrast Effects of Low Dose and Moderate/Chronic Alcohol on Vascular 
Smooth Muscles 
 
To find out the reasons why chronic alcohol diminished PVS clearance efficiency, we 
studied two vascular components: smooth muscles and endothelium. The ratioale was 
that according to previous findings, PVS clearance was mediated by dilative vascular 
reactivities, which were regulated by endothelium and smooth muscles interaction. 
Firstly, we investigated vascular smooth muscles. Immunostaining of α-SMCs 
(smooth muscel actin, red) showed increasing expression in the low/acute alcohol group 
compared with control whereas expression of α-SMCs in the chronic condition was 
decreased (Figure 5.2A). The observation was validated by quantitative assay western 
blot (Figure 5.2B), collectively suggesting that chronic alcohol intake impaired smooth 
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muscle actins, which respresents the architectural structure of smooth muscle cells.  
We further examined the phosphorylation level of myosin light chain (MLC), 
which represents the contraction (phosphorylation) or relaxation (de-phosphorylation) 
status of smooth muscles. Immunostaining (smooth muscle specific p-MLC, green) 
showed that phosphorylation level of MLC was decreased by low dose (Figure 5.2 A), 
indicating enhanced dilative vascular reactivities. Whereas in the chronic condition, p-
MLC level was increased, suggesting that the vascular dilative reactivities were 
diminished. The observation was validated by quantitative assay western blot (Figure 
5.2 B). As such, the summary is that chronic alcohol intake impaired vascular smooth 
muscles and decreased dilative vascular reactivities.  
 
Figure 5.2 Effect of low dose and chronic alcohol intake on vascular smooth muscle 
reactivity. [A].Immunostaining of SMA (red) and smooth muscle specific phospho-
MLC (green) protein at brain microvessels (indicated by structures) in control, low dose 
EtOH and chronic EtOH treatment. SMA and p-MLC were used as primary antibodies. 
Data was representation of at least N=6 animals per each group. Scale bar: 30 μm.  [B]. 
Immunoreactive bands of SMA, p-MLC and β-actin, and quantitative corresponding 
protein content in three experimental groups. Results were expressed as the ratio of 
protein of interest to that of actin bands and presented as mean values (± SEM). 
Statistically significant (*p<0.05) compared with controls. Three replicates were done 
for each animal sample from at least N=6 animals. 
 
5.3.4 Contrast Effect of Low Dose and Moderate/chronic Alcohol on Brain 
Vascular Endothelial cells and the Blood-Brain Barrier (BBB) 
 
To investigate the effect of alcohol on brain vascular endothelial cells, we evaluated the 
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immunoreactivity of endothelial cell markers, von willebrand factor (vWF) and glucose 
transporter 1 (Glut-1). Immunostaining revealed that chronic alcohol intake diminished 
aimed proteins’ (vWF and Glut-1) expressions while there was no change for low/acute 
exposure, which was further validated by western blot analyses (*p<0.05) (Figure 5.3). 
These results indicated that chronic alcohol impaired brain vascular endothelial cells 
compared with control and low dose.  
Next, we procceded to investigate the integrity of blood-brain barriers (BBB), 
which were localized on the endothelium. We examined changes in expression of BBB 
tight junction (TJ) proteins: occludin, claudin-5 and zonula occluden 1 (ZO-1) by 
immunostaining and western blot since reduction in TJ protein levels or disruption of 
the architectural structure of any TJ protein was expected to impair BBB integrity. 
Immunostaining revealed that moderate/chronic alcohol exposure diminished 
expression of TJ proteins at brain microvessels compared with control (Figure 5.4A) 
while no significant change was observed in low/acute alcohol. These alcohol dosing-
induced changes in TJ protein expressions were validated by western blot, and 
quantification of the TJ protein immunoreactive bands (p<0.05) (Figure 5.4B). This 
data was in agreement with previous findings that chronic alcohol abuse leads to 
breaking of the BBB [88, 89, 111]. 
In summary, we concluded that moderate/chronic alcohol intake impaired brain 
vascular endoethelial cells and compromised BBB integrities.  
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Figure 5.3 Effect of low dose and chronic alcohol intake on vascular endothelial cells. 
Coronal tissue sections (10 ~ 15 μm) were analyzed for endothelial cell markers (vWF 
and Glut-1: red) subcellular distribution while protein extracts from brain were analyzed 
for alterations in corresponding protein content. [A]. Immunostaining of vWF (red) and 
Glut-1 (red) protein around brain microvessels (indicated by circular structures) in 
control, low dose EtOH and chronic EtOH treatment. vWF and Glut-1 were used as 
primary antibodies (information in Table 2.1). Scale bar: 30 μm. Data was representation 
of at least N=6 animals per each group. [B]. Immunoreactive bands of vWF, Glut-1 and 
β-actin, and quantitative corresponding protein content in three experimental groups. 
Results are expressed as the ratio of protein of interest to that of actin bands and 
presented as mean values (± SEM). Statistically significant (*p < 0.05) compared with 
controls. Three replicates were done for each animal sample from at least N=6 animals. 
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Figure 5.4 Effect of low dose and chronic alcohol intake on BBB tight junction proteins. 
[A]. Immunostaining of tight junction proteins: ZO-1, Occludin and Claudin-5 (red) in 
brain microvessels from coronal slices (10 ~ 15 μm) of control, low dose EtOH and 
chronic EtOH. ZO-1, Occludin and Claudin-5 were used as primary antibodies 
(information in Table 2.1). Scale bar: 30 μm. Data was representation of at least N=6 
animals per each group. [B]. Western blot analysis of ZO-1, Occludin, Claudin-5 and β-
actin in the whole brain tissue homogenates of rats at different experimental conditions. 
Results are expressed as the ratio of protein of interest to that of actin bands and 
presented as mean values (± SEM). Statistically significant (*p < 0.05) compared with 
controls. Three replicates were done for each animal sample from at least N=6 animals. 
 
5.3.5 Induction of Free Radicals by Alcohol Causes Vasculature Damage 
 
From previous data, it was shown that smooth muscles, endothelium and BBB integrities 
were impaired under chronic alcohol exposure. To find out the likely reasons that caused 
these observations, we focused on free radical generation - particularly the iNOS 
mediated nitrosative stress on brain vasculatures. Level of 3-nitrotyrosine (3-NT) was 
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the indicator of nitrosative stress, as it leads to formation of nitrated proteins. 
Immunostaining of 3-NT revealed that protein level was increased in the chronic 
condition while no change in the low/acute when compared with control (Figure 5.5A). 
Using the western blot assay, we detected three nitrotyrosine proteins (molecular 
weights of 210, 97, and 68 kDa). The 210‐kDa protein was the major nitrated protein as 
compared with 97 kDa or 68 kDa nitrated proteins. Quantitative data validated our 
finding that chronic exposure significantly increased 3-NT expression (Figure 5.5B) 
(*p<0.05).  The extent of nitrosative damage marker 3NT paralleled induction of iNOS, 
indicating that free radical damage was correlated with iNOS over-expression. eNOS 
expression was elevated under low dose condition, which lined-up with previous 
observations.  
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Figure 5.5 Effect of low dose and chronic alcohol intake on free radical generation. 
Coronal tissue sections (10 ~ 15 μm) were analyzed for eNOS, iNOS and 3-NT 
(nitrosative stress markers) subcellular distribution while protein extracts from brain 
were analyzed for alterations in corresponding protein content. [A]. Immunostaining of 
eNOS (red), iNOS (red) and 3-NT (red) protein at brain microvessels (indicated by 
structures) in control, low dose EtOH and chronic EtOH. eNOS, iNOS and 3-NT were 
used as primary antibodies (information in Table 2.1). Scale bar: 30 μm. Data was 
representation of at least N=6 animals per each group. [B]. Immunoreactive bands of 
eNOS, iNOS, 3-NT and β-actin, and quantitative corresponding protein content in three 
experimental groups. Results were expressed as the ratio of protein of interest to that of 
actin bands and presented as mean values (± SEM). Statistically significant (*p < 0.05) 
compared with controls. Three replicates were done for each animal sample from at least 
N=6 animals. 
 
Thus, these data above collectively suggested that iNOS mediated nitrosative 
stress leads to free radical damage at brain vasculatures when exposed to the 
moderate/chronic alcohol whereas no such effect was found on the low/acute. 
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5.4 Discussion 
We discuss the finding of contrast effects of alcohol (acute/low and moderate/chronic) on 
brain PVS waste metabolites clearance. In a previous study [62], we used low levels of 
alcohol to understand the protective mechanisms of promoting perivascular clearance 
because low alcohol use was protective of vascular and cardiovascular function [4, 64, 65, 
85-87]. We found that low dose alcohol intake (5 mM) can increase interaction of brain 
vascular ECs-SMCs. Large size waste metabolites clearance in the brain that cannot be 
efficiently done through CSF, glymphatic, or meningeal lymphatic systems were able to 
be facilitated by alcohol through this mechanism. In fact, Lundgaard et al. (2018) showed 
the beneficial effects of low dose alcohol and the adverse effects of high dose alcohol on 
glymphatic function [85]. We noted here that the contrast effects of low dose alcohol 
intake and chronic use of moderate-to-high dose alcohol (equivalent of alcohol dependent 
subjects) were examined in the context of vascular reactivity, blood-brain barrier 
permeability and perivascular clearance since epidemiological evidence showed 
distinctive consequences on brain clearance and associated neurological diseases (e.g., 
Alzheimer’s disease and cerebral amyloid angiopathy) under different alcohol drinking 
patterns as discussed previously [5, 77, 80, 81, 83, 84, 125, 126]. The data indicated that 
chronic alcohol hampered perivascular waste metabolites clearance, impaired dilative 
vascular reactivities and compromised BBB integrity, due to: 1) paradigm shift to iNOS 
in chronic conditions and 2) free radical damage induced by alcohol impaired brain 
microvessels during moderate/chronic alcohol exposure.  
To mimic the large size waste metabolites, we injected a large molecular weight 
fluorescent tracer (2000 KD) as proof-of-concept. We showed the contrast phenomenon 
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by examining the bio-distribution of large size molecular weight fluorescent tracer 
through cisterna magna injection under low/acute and moderate/chronic conditions 
(Figure 5.1). We found that low/acute alcohol enhanced dynamic tracer movement and 
clearance while moderate/chronic hampered this process. Further evidence showed that 
vascular smooth muscles and endothelium were impaired and BBB intergrites were 
compromised under chronic alcohol conditons (Figures 5.2 – 5.4), indicating that the 
vascular dilative reactivities that are regulated by endothelial-smooth muscle interaction 
were diminished. 
We also examined the expression of iNOS (Figure 5.5), which mediated free 
radical generating due to elevation of high amounts of NO compared with that of eNOS. 
Interestingly, iNOS showed an opposite expression pattern compared with eNOS. We 
then showed that free radical damages (3-NT) (Figure 5.5) that induced by chronic 
alcohol exposure impaired brain microvessels, which were in parallel with iNOS 
expression.  
Collectively, the contrast effects of acute/low and chronic/moderate alcohol intake 
were examined in this chapeter. It was found that unlike low dose, moderate/chronic 
alcohol intake diminished PVS clearance compared with control. The contrast effects 
were due to that moderate/chronic alcohol induced free radical generation, which led to 
impairement of vascular endothelium and smooth muscles, dysfunction of BBB and 
decreased vascular dilative reactivities. The significance of this work is the discovery 
that mis-use/chronic alcohol abuse impairs the brain clearance system, which may lead 
to onset/progression of neurodeneration diseases, like Alzheimer’s disease, supporting 
by epidemiological studies that discussed previously.  
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Figure 5.6 Illustration of Chapter 5. Left: Arrows (orange) indicate the CSF 
subarachnoid flow and perivascular-perivenous clearance path (black) of large size 
waste metabolites (red dots) in the neurodegenerative brain. Waste metabolites like beta-
amyloid proteins are aggregated more inside the interstitial space due to the lack of a 
lymphatic system in the brain. Less metabolites drain into the CSF flows due to less 
vessel dilative reactivity. Right top: The neurodegenerative brain in the presence of low 
dose alcohol. Dilative arterial vessel reactivity promotes the dynamic movement of large 
size waste metabolites from interstitial fluid to perivascular space and from interstitial-
CSF subarachnoid to perivascular space. Reactivity of endothelial and smooth muscle 
cells in arteries is mediated by alcohol-initiated eNOS activation and NO production. 
Right bottom: The neurodegenerative brain exposed to chronic/moderate alcohol intake. 
Loss of dilative arterial vessel reactivity due to free radical damage towards vasculatures 
hampers the dynamic movement of waste metabolites to the perivascular – peri-venous 
route. Paradigm shift from eNOS to iNOS initiates free radical generation and causes 
diminishing reactivity of endothelial and smooth muscle cells in arterial vasculatures 
with chronic/moderate alcohol exposure. 
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CHAPTER 6 
SUMMARY CONCLUSION  
 
Efficient clearance of the interstitial waste metabolites is essential for normal 
maintenance of brain homeostasis. The brain lacks the lymphatic clearance system – 
thus clearance of waste metabolites in the brain is dependent on cerebrospinal fluid 
(CSF) system. The recent discovery glymphatic system claims that the direct bulk flow 
transports small size water-soluble waste metabolites into to the perivenous space by 
aquaporin-4 water channels of the astrocyte end-feet, but it does not account for the 
clearance of large size waste metabolites, like peptide and/or protein aggregations.  
Here, the clearance mechanisms of large size waste metabolites from interstitial 
fluid to the perivascular space as well as from the CSF subarachnoid into perivascular 
space via the paravascular drainage is investigated. A low dose ethanol (5 mM) is found 
to promote the dynamic clearance of waste metabolites through this perivascular-
perivenous drainage path. This ethanol-induced effect can be explained by the findings 
that activation of endothelial specific nitric oxide synthase (eNOS) by ethanol and 
generation of vasodilator nitric oxide (NO) mediate the interactive reactivity of 
endothelial-smooth muscle cells. Futher evidence reveals that NO mediated ECs and 
SMCs interaction is regulated by myosin light chain activities, which depend on the 
balance between two opposite enzymatic acitivies: myosin light chain kinase and 
myosin light chain phosphatase.  
In addition to that, the contrast effects of acute low dose and chronic moderate 
alcohol intake on BBB associated perivascular clearance of waste metabolites in the 
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brain is also examined. The underlying molecular and cellular mechanisms that drive 
the increase or decrease movement of tracer to perivascular space by acute/chronic 
alcohol exposure are correlated to BBB integrity and arterial vessel reactivity. Evidently, 
the contrast effects of alcohol appear to be regulated by the switch mechanisms of 
endothelial specific nitric oxide synthase (eNOS) activation by low dose and inducible 
NOS (iNOS) by moderately high alcohol exposure in chronic conditions. As such, it is 
concluded that low dose alcohol promotes the diffusive movement of waste metabolites 
to perivascular clearance through eNOS-derived NO regulated arterial endothelial-
smooth muscle cell dilative reactivity without affecting the integrity of the BBB. 
Whereas, continuous induction of iNOS in chronic alcohol exposure causes oxidative 
damage of the arterial endothelial-smooth muscle layers that led to BBB dysfunction, 
reduced dilative reactivity, and decreased movement of waste metabolites from 
interstitial space/CSF to perivascular-perivenous drainage path.  
Given the fact that large size waste metabolites like tauopathy, prion-like 
proteinopathies, cerebral amyloid angiopathy, and Aβ proteins are seen accumulated 
around the perivascular space in brain tissue from neurological diseases, the significance 
of this current work affords new therapeutical strategies for neurological diseases, 
particarly the timely clearance of entangled proteins.  
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APPENDIX A 
MATLAB CODE FOR COMPUTING VESSEL DIAMETER CHANGE 
This code is used to calculate vessel diameters that present in Chapter 3. 
 
%% 
folderContents = dir; 
nFiles = length(dir); 
 
arteryFiles = cell(nFiles,1); 
nVids = 0; 
for i = 1:nFiles 
filename = folderContents(i).name; 
if length(filename) > 3 && strcmpi(filename(1:2),'T=') && strcmpi(filename(end-3:end),'.avi') 
nVids = nVids + 1; 
arteryFiles{nVids} = filename; 
end 
end 
 
arteryFiles = arteryFiles(1:nVids); 
exposureTimes = zeros(nVids,1); 
for i = 1 :nVids 
exposureTimes(i) = str2double(arteryFiles{i}(3:end-4)); 
end 
 
%% 
nDivisions = 5; 
peakQuantile = .9; 
pixelLength = 40/38; 
vesselDiameterYLim = [15,35]; 
interpFactor = 8; 
 
frameRate = 4; 
borderFraction = .1; 
 
vesselDiameters = cell(nVids,1); 
 
 
for i = 1:nVids 
vw = VideoWriter(['T',num2str(exposureTimes(i)),'_vessel_diameters']); %#ok<TNMLP> 
vw.FrameRate = frameRate; 
open(vw); 
 
cf = figure('units','normalized','outerposition',[0 0 1 1]); 
 
%     set(cf,'visible','off') 
exposureTimes(i) = str2double(arteryFiles{i}(3:end-3)); 
currentVideo = importdata(arteryFiles{i}); 
 
nX = size(currentVideo(1).cdata,2); 
nY = size(currentVideo(1).cdata,1); 
nFrames = length(currentVideo); 
 
vesselDiameters{i} = zeros(nFrames,nDivisions); 
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for j = 1:nFrames; 
iRed = currentVideo(j).cdata(:,:,1); 
iFilt = double(iRed); 
iFilt = filter2(eye(3)/9,iFilt); 
iFilt = medfilt2(iFilt,[1,3]); 
 
 
clf 
subplot(1,3,1) 
imshow(currentVideo(j).cdata) 
 
 
for k = 1:nDivisions 
 
 
 
y = round(k/(nDivisions+1)*(nY*(1-2*borderFraction)) + nY*borderFraction); %divide up only the 
middle half to avoid text at head and foot of video 
interpX = linspace(1,nX,nX*interpFactor); 
 
lineVals = interp1((1:nX),iFilt(y,:),interpX); 
mpp = 2*median(lineVals); 
[~, peaks] = findpeaks(lineVals,'MinPeakProminence',mpp); 
 
if numel(peaks) > 1 
leftPeak = min(peaks); 
rightPeak = max(peaks); 
vesselDiameters{i}(j,k) = range(interpX(peaks))*pixelLength; 
%                 vesselDiameters{i}(j,k) = min(diff(sort((interpX(peaks))*pixelLength))); 
else 
vesselDiameters{i}(j,k) = 0; 
end 
 
 
 
 
 
subplot(1,3,1) 
hold on 
plot([1,nX],[y,y],'b','linewidth',2) 
if ~isempty(peaks) 
plot(interpX(peaks),y,'w.','markersize',12) 
end 
 
subplot(nDivisions,3,2+(k-1)*3) 
hold on 
plot(interpX,lineVals,'linewidth',2) 
plot(interpX(peaks),lineVals(peaks),'k.','markersize',12); 
 
 
if k == 1 
title(arteryFiles{i}(1:end-4)) 
end 
 
if k == nDivisions 
xlabel('distance (\mum)') 
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end 
ylabel('relative intensity') 
 
subplot(nDivisions,3,3+(k-1)*3) 
hold on 
plot((0:j-1)/frameRate,vesselDiameters{i}(1:j,k),'.') 
xlim([0,nFrames]/frameRate) 
ylim(vesselDiameterYLim) 
 
if k == nDivisions 
xlabel('time (s)') 
end 
ylabel('distance (\mum)') 
 
 
 
end 
 
set(cf,'color','w') 
vw.writeVideo(getframe(cf)); 
%         pause(.01) 
end 
close(vw) 
 
 
end 
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APPENDIX B 
R CODE FOR VESSEL DIAMETER DATA PROCESS AND PLOTTING 
 
This code is used to generate plots that present in Chapter 3. 
 
# read data 
T0<-read.csv('T=0.csv',header = F) 
T15<-read.csv('T=15.csv',header = F) 
T30<-read.csv('T=30.csv',header = F) 
T45<-read.csv('T=45.csv',header = F) 
 
# rename column 
colnames(T0)<-c('Frame','1','2','3','4','5') 
colnames(T15)<-c('Frame','1','2','3','4','5') 
colnames(T30)<-c('Frame','1','2','3','4','5') 
colnames(T45)<-c('Frame','1','2','3','4','5') 
 
# add label 
T0$time<-'baseline' 
T15$time<-'15 min after alcohol' 
T30$time<-'30 min after alcohol' 
T45$time<-'45 min after alcohol' 
 
# plot 
T0reshape<-melt(T0,id.vars = 'Frame') 
T0reshape$variable<-NULL 
T0reshape$Frame<-as.factor(as.character(T0reshape$Frame)) 
T0sum<- 
  T0reshape%>% 
  group_by(Frame)%>% 
  summarise(mean=mean(value),sd=sd(value)) 
T0sum$Frame<- 
  as.numeric(as.character(T0sum$Frame)) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
  geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
  geom_point()+ 
  geom_line(data = spline_int,aes(x=x,y=y)) 
spline_int<-as.data.frame(spline(T0sum$Frame, T0sum$mean)) 
 
 
plotfunction<-function(a){ 
  x1<-melt(a,id.vars = 'Frame') 
  x1$variable<-NULL 
  x1$Frame<-as.factor(as.character(x1$Frame)) 
  x2<- 
    x1%>% 
    group_by(Frame)%>% 
    summarise(mean=mean(value),sd=sd(value)) 
  x2$Frame<- 
    as.numeric(as.character(x2$Frame)) 
  spline_int<-as.data.frame(spline(x2$Frame, x2$mean)) 
  ggplot(x2,aes(x=Frame,y=mean))+ 
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    geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
    geom_point()+ 
    geom_line(data = spline_int,aes(x=x,y=y)) 
} 
 
plotfunction(T30) 
 
T30<-T30[-12,] 
T30 
row.names(T30) <- 1:nrow(T30) 
ggplot(data=T30,aes(x=Frame,y=mean))+geom_point() 
 
# encoding time lapse 
 
T15$Frame<-T15$Frame+40 
T30$Frame<-T30$Frame+77 
T45$Frame<-T45$Frame+116 
 
combine<-rbind(T0,T15,T30,T45) 
combine<-combine[-c(89,90),] 
combine[combine$time=='30 min after alcohol','Frame']<-seq(78,114) 
combine[combine$time=='45 min after alcohol','Frame']<-seq(115,191) 
 
combine_reshape<-melt(combine,id.vars = c('Frame','time')) 
 
combine_reshape$Frame<-as.factor(as.character(combine_reshape$Frame)) 
 
combine_reshape_sum<- 
  combine_reshape%>% 
  group_by(Frame)%>% 
  summarise(mean=mean(value),sd=sd(value)) 
combine_reshape_sum$Frame<- 
  as.numeric(as.character(combine_reshape_sum$Frame)) 
 
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45 min after alcohol', 
                                  ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 
min after alcohol', 
                                         
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after 
alcohol','baseline'))) 
 
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse) 
is.factor(combine_reshape_sum$timelapse) 
combine_reshape_sum$label<-NULL 
 
# Plot for the combine 
 
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean)) 
 
p<- 
  ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
  geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
  geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
  scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
  theme(legend.title=element_blank()) 
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# add theme 
p+xlab("Frame")+ylab("Diameter (um)")+ 
  ggtitle("Cerebral vessel diameter change under low dose alochol")+ 
  theme(axis.title.x = element_text(size=15), 
        axis.title.y = element_text(size=15), 
        axis.text.x=element_text(color="Black",size=10), 
        axis.text.y = element_text(color="Black",size=10), 
        plot.title = element_text(size=15,hjust=0.5), 
        panel.background = element_rect(fill='White',color='Black')) 
# plot 
T0reshape<-melt(T0,id.vars = 'Frame') 
T0reshape$variable<-NULL 
T0reshape$Frame<-as.factor(as.character(T0reshape$Frame)) 
grouped<-group_by(T0reshape,Frame) 
summarise(grouped,mean=mean(value),sd=sd(value)) 
T0sum<- 
T0reshape%>% 
group_by(Frame)%>% 
summarise(mean=mean(value),sd=sd(value)) 
View(T0sum) 
T0sum$Frame<- 
as.numeric(as.character(T0sum$Frame)) 
View(T0sum) 
geom_errorbar(aes(ymin=mean-sd, ymax=mean+sd), width=.1) + 
library("ggplot2", lib.loc="~/R/win-library/3.4") 
ggplot(T0sum, aes(x=Frame, y=mean) + 
str(T0sum) 
str(T0sum) 
summary(T0sum) 
geom_errorbar(aes(ymin=mean-sd, ymax=mean+sd), width=.1) + 
geom_point() 
geom_line() + 
gplot(T0sum, aes(x=Frame, y=mean) + 
geom_errorbar(aes(ymin=mean-sd, ymax=mean+sd), width=.1) + 
geom_line() + 
geom_point() 
gplot(T0sum, aes(x=Frame, y=mean) 
gplot(T0sum, aes(x=Frame, y=mean)+geom_errorbar(aes(ymin=mean-sd, ymax=mean+sd), width=.1) + 
ggplot(T0sum,aes(x=Frame,y=mean)) 
ggplot(T0sum,aes(x=Frame,y=mean)) 
View(T0sum) 
ggplot(T0sum,aes(x=Frame,y=mean)) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point() 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+geom_line() 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
stat_smooth(aes(x=Frame,y=mean),method = 'lm', 
formula = y~ploy(x,39)) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
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geom_point()+ 
stat_smooth(aes(x=Frame,y=mean),method = 'lm', 
formula = y~poly(x,39)) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
stat_smooth(aes(x=Frame,y=mean),method = 'lm', 
formula = y~poly(x,10)) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
stat_smooth(aes(x=Frame,y=mean),method = 'lm', 
formula = y~poly(x,38)) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
stat_smooth(aes(x=Frame,y=mean),method = 'lm', 
formula = y~poly(x,30)) 
formula = y~poly(x,20) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
stat_smooth(aes(x=Frame,y=mean),method = 'lm', 
formula = y~poly(x,20)) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point() 
spline_int<-as.data.frame(spline(T0sum$Frame, T0sum$mean)) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
plotfunction<-function(a){ 
x1<-melt(a,id.vars = 'Frame') 
x1$variable<-NULL 
x1$Frame<-as.factor(as.character(x1$Frame)) 
x2<- 
x%>% 
group_by(Frame)%>% 
summarise(mean=mean(value),sd=sd(value)) 
x2$Frame<- 
as.numeric(as.character(x2$Frame)) 
spline_int<-as.data.frame(spline(x2$Frame, x2$mean)) 
ggplot(x2,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
} 
plotfunction(T0) 
plotfunction(T0) 
T0reshape<-melt(T0,id.vars = 'Frame') 
T0reshape$variable<-NULL 
T0reshape$Frame<-as.factor(as.character(T0reshape$Frame)) 
T0sum<- 
T0reshape%>% 
group_by(Frame)%>% 
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summarise(mean=mean(value),sd=sd(value)) 
T0sum$Frame<- 
as.numeric(as.character(T0sum$Frame)) 
ggplot(T0sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
spline_int<-as.data.frame(spline(T0sum$Frame, T0sum$mean)) 
plotfunction<-function(a){ 
x1<-melt(a,id.vars = 'Frame') 
x1$variable<-NULL 
x1$Frame<-as.factor(as.character(x1$Frame)) 
x2<- 
x1%>% 
group_by(Frame)%>% 
summarise(mean=mean(value),sd=sd(value)) 
x2$Frame<- 
as.numeric(as.character(x2$Frame)) 
spline_int<-as.data.frame(spline(x2$Frame, x2$mean)) 
ggplot(x2,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
} 
plotfunction(T0) 
plotfunction(T15) 
plotfunction(T30) 
plotfunction(T45) 
View(T45) 
View(T30) 
T45<-read.csv('T=45.csv',header = F) 
colnames(T45)<-c('Frame','1','2','3','4','5') 
plotfunction(T45) 
View(T0) 
View(T15) 
View(T30) 
View(T45) 
# add label 
T0$time<-'baseline' 
T15$time<-'15 min after alcohol' 
T30$time<-'30 min after alcohol' 
T45$time<-'45 min after alcohol' 
View(T0) 
combine<-rbind(T0,T15,T30,T45) 
View(combine) 
View(T0) 
View(T15) 
T15$Frame<-T15$Frame+40 
View(T15) 
View(T15) 
View(T30) 
T30$Frame<-T30$Frame++77 
View(T30) 
T30$Frame<-T30$Frame+77 
View(T30) 
T30<-read.csv('T=30.csv',header = F) 
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colnames(T30)<-c('Frame','1','2','3','4','5') 
T30$time<-'30 min after alcohol' 
View(T30) 
T30$Frame<-T30$Frame+77 
T45$Frame<-T45$Frame+116 
combine<-rbind(T0,T15,T30,T45) 
View(combine) 
combine_reshape<-melt(combine,id.vars = 'Frame') 
View(combine_reshape) 
combine<-rbind(T0,T15,T30,T45) 
combine_reshape<-melt(combine,id.vars = c('Frame','time')) 
View(combine_reshape) 
combine$Frame<-as.factor(as.character(combine$Frame)) 
combine<-rbind(T0,T15,T30,T45) 
combine_reshape$Frame<-as.factor(as.character(combine_reshape$Frame)) 
combine_reshape_sum<- 
combine_reshape%>% 
group_by(Frame)%>% 
summarise(mean=mean(value),sd=sd(value)) 
combine_reshape_sum$Frame<- 
as.numeric(as.character(combine_reshape_sum$Frame)) 
View(combine_reshape_sum) 
View(combine_reshape_sum) 
View(combine_reshape) 
combine_reshape_sum<- 
combine_reshape%>% 
group_by(Frame)%>% 
summarise(time=time,mean=mean(value),sd=sd(value)) 
combine_reshape_sum$Frame<- 
as.numeric(as.character(combine_reshape_sum$Frame)) 
View(combine_reshape_sum) 
View(combine_reshape_sum) 
View(T0) 
View(T15) 
View(T30) 
View(T45) 
combine_reshape_sum$label<-ifelse(combine_reshape_sum$Frame>=117,'45min after alcohol', 
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol', 
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after 
alcohol','baseline'))) 
View(combine_reshape_sum) 
is.numeric(combine_reshape_sum$Frame) 
# Plot for the combine 
spline_int<-as.data.frame(spline(combine_reshape_sum$Frame, combine_reshape_sum$mean)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=label))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y,color=label)) 
View(combine_reshape_sum) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
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geom_line(data = spline_int,aes(x=x,y=y)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=label))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=label),inherit.aes = FALSE)+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45min after alcohol', 
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol', 
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after 
alcohol','baseline'))) 
View(combine_reshape_sum) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+ 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
combine_reshape_sum$label<-NULL 
combine_reshape_sum$label<-NULL 
View(combine_reshape_sum) 
# Plot for the combine 
spline_int<-as.data.frame(spline(combine_reshape_sum$Frame, combine_reshape_sum$mean)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+ 
geom_point()+ 
head(combine_reshape_sum) 
head(combine_reshape_sum) 
head(combine_reshape_sum) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+ 
geom_point()+ 
head(combine_reshape_sum) 
head(combine_reshape_sum) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
# Plot for the combine 
spline_int<-as.data.frame(spline(combine_reshape_sum$Frame, combine_reshape_sum$mean)) 
geom_point()+geom_line(data = spline_int,aes(x=x,y=y)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+ 
geom_point()+geom_line(data = spline_int,aes(x=x,y=y)) 
head(combine_reshape_sum) 
p<-ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse) 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+geom_line(data = spline_int,aes(x=x,y=y)) 
p<-ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)) 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data = 
spline_int,aes(x=x,y=y)) 
p<-ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data = 
spline_int,aes(x=x,y=y)) 
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p 
View(combine_reshape_sum) 
is.factor(combine_reshape_sum$timelapse) 
is.character(combine_reshape_sum$timelapse) 
as.factor(combine_reshape_sum$timelapse) 
is.factor(combine_reshape_sum$timelapse) 
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse) 
is.factor(combine_reshape_sum$timelapse) 
spline_int<-as.data.frame(spline(combine_reshape_sum$Frame, combine_reshape_sum$mean)) 
ggplot(data=combine_reshape_sum, 
aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data = 
spline_int,aes(x=x,y=y)) 
ggplot(data=combine_reshape_sum, 
aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data = 
spline_int,aes(x=x,y=y,color=timelapse)) 
ggplot(data=combine_reshape_sum, 
aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data = 
spline_int,aes(x=x,y=y)) 
ggplot(data=combine_reshape_sum, 
aes(x=Frame,y=mean,colour=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data = 
spline_int,aes(x=x,y=y)) 
ggplot(data=combine_reshape_sum, 
aes(x=Frame,y=mean,fill=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data = 
spline_int,aes(x=x,y=y)) 
ggplot(data=combine_reshape_sum, 
aes(x=Frame,y=mean,fill=timelapse))+geom_point()+geom_line(data = spline_int,aes(x=x,y=y)) 
ggplot(data=combine_reshape_sum, 
aes(x=Frame,y=mean,color=timelapse))+geom_point()+geom_line(data = spline_int,aes(x=x,y=y)) 
summary(combine_reshape_sum) 
ggplot(data=combine_reshape_sum, 
aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data = 
spline_int,aes(x=x,y=y)) 
ggplot(combine_reshape_sum) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point() 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_linegeom_line(data = spline_int,aes(x=x,y=y)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE) 
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spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean)) 
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, 
y=combine_reshape_sum$mean,color=combine_reshape_sum$timelapse)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
scale_fill_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
theme(legend.title=element_blank()) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
theme(legend.title=element_blank()) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
theme(legend.title=element_blank()) 
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45 min after alcohol', 
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol', 
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after 
alcohol','baseline'))) 
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse) 
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
theme(legend.title=element_blank()) 
combine_reshape_sum[,combine_reshape_sum$mean<10] 
combine_reshape_sum[combine_reshape_sum$mean<10,] 
backup<-combine_reshape_sum 
backup[backup$mean<10,]<-NULL 
backup[66,] 
backup[89,] 
backup[89,] 
View(combine_reshape_sum) 
View(combine_reshape_sum) 
backup[182,] 
backup<-backup[-182,] 
View(backup) 
ggplot(backup,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
theme(legend.title=element_blank()) 
T30 
T30[-12,] 
T30<-T30[-12,] 
T30 
plotfunction(T30) 
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plotfunction<-function(a){ 
x1<-melt(a,id.vars = 'Frame') 
x1$variable<-NULL 
x1$Frame<-as.factor(as.character(x1$Frame)) 
x2<- 
x1%>% 
group_by(Frame)%>% 
summarise(mean=mean(value),sd=sd(value)) 
x2$Frame<- 
as.numeric(as.character(x2$Frame)) 
spline_int<-as.data.frame(spline(x2$Frame, x2$mean)) 
ggplot(x2,aes(x=Frame,y=mean))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+ 
geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y)) 
} 
plotfunction(T30) 
ggplot(data=T30,aes(x=Frame,y=mean))+geom_line 
ggplot(data=T30,aes(x=Frame,y=mean))+geom_line() 
ggplot(data=T30,aes(x=Frame,y=mean))+geom_point() 
row.names(T30) <- 1:nrow(T30) 
ggplot(data=T30,aes(x=Frame,y=mean))+geom_point() 
View(T30) 
T30 
View(T0) 
View(T15) 
View(T30) 
T30$Frame<-T30$Frame+77 
T30<-read.csv('T=30.csv',header = F) 
colnames(T30)<-c('Frame','1','2','3','4','5') 
T30$time<-'30 min after alcohol' 
T30$Frame<-T30$Frame+77 
View(T30) 
View(T45) 
combine<-rbind(T0,T15,T30,T45) 
combine_reshape<-melt(combine,id.vars = c('Frame','time')) 
combine_reshape$Frame<-as.factor(as.character(combine_reshape$Frame)) 
combine_reshape_sum<- 
combine_reshape%>% 
group_by(Frame)%>% 
summarise(mean=mean(value),sd=sd(value)) 
combine_reshape_sum$Frame<- 
as.numeric(as.character(combine_reshape_sum$Frame)) 
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45 min after alcohol', 
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol', 
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after 
alcohol','baseline'))) 
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse) 
is.factor(combine_reshape_sum$timelapse) 
combine_reshape_sum$label<-NULL 
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
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theme(legend.title=element_blank()) 
View(combine_reshape_sum) 
View(combine) 
View(combine_reshape) 
View(combine) 
combine<-combine[-89,] 
View(combine) 
combine<-combine[-c(89,90),] 
combine[combine$time=='30 min after alcohol',] 
combine[combine$time=='30 min after alcohol','Frame'] 
combine[combine$time=='30 min after alcohol','Frame']<-seq(78,114) 
seq(78,114) 
combine<-rbind(T0,T15,T30,T45) 
combine<-combine[-c(89,90),] 
combine[combine$time=='30 min after alcohol','Frame'] 
combine[combine$time=='30 min after alcohol','Frame']<-seq(78,114) 
combine[combine$time=='45 min after alcohol','Frame'] 
combine[combine$time=='45 min after alcohol','Frame']<-seq(115,191) 
combine_reshape<-melt(combine,id.vars = c('Frame','time')) 
combine_reshape$Frame<-as.factor(as.character(combine_reshape$Frame)) 
combine_reshape_sum<- 
combine_reshape%>% 
group_by(Frame)%>% 
summarise(mean=mean(value),sd=sd(value)) 
combine_reshape_sum$Frame<- 
as.numeric(as.character(combine_reshape_sum$Frame)) 
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45 min after alcohol', 
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol', 
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after 
alcohol','baseline'))) 
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse) 
is.factor(combine_reshape_sum$timelapse) 
combine_reshape_sum$label<-NULL 
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean)) 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
theme(legend.title=element_blank()) 
P<- 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
theme(legend.title=element_blank()) 
p<- 
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+ 
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+ 
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+ 
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after 
alcohol'))+ 
theme(legend.title=element_blank()) 
p 
# add theme 
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p+xlab("Frame")+ylab("Diameter (um)")+ 
ggtitle("Cerebral vessel diameter change under low dose alochol")+ 
theme(axis.title.x = element_text(size=20), 
axis.title.y = element_text(size=20), 
axis.text.x=element_text(color="Black",size=15), 
axis.text.y = element_text(color="Black",size=15), 
plot.title = element_text(size=20,hjust=0.5)) 
# add theme 
p+xlab("Frame")+ylab("Diameter (um)")+ 
ggtitle("Cerebral vessel diameter change under low dose alochol")+ 
theme(axis.title.x = element_text(size=10), 
axis.title.y = element_text(size=10), 
axis.text.x=element_text(color="Black",size=5), 
axis.text.y = element_text(color="Black",size=5), 
plot.title = element_text(size=10,hjust=0.5)) 
# add theme 
p+xlab("Frame")+ylab("Diameter (um)")+ 
ggtitle("Cerebral vessel diameter change under low dose alochol")+ 
theme(axis.title.x = element_text(size=15), 
axis.title.y = element_text(size=15), 
axis.text.x=element_text(color="Black",size=10), 
axis.text.y = element_text(color="Black",size=10), 
plot.title = element_text(size=15,hjust=0.5)) 
# add theme 
p+xlab("Frame")+ylab("Diameter (um)")+ 
ggtitle("Cerebral vessel diameter change under low dose alochol")+ 
theme(axis.title.x = element_text(size=15), 
axis.title.y = element_text(size=15), 
axis.text.x=element_text(color="Black",size=10), 
axis.text.y = element_text(color="Black",size=10), 
plot.title = element_text(size=15,hjust=0.5), 
panel.background = element_rect(fill='White')) 
# add theme 
p+xlab("Frame")+ylab("Diameter (um)")+ 
ggtitle("Cerebral vessel diameter change under low dose alochol")+ 
theme(axis.title.x = element_text(size=15), 
axis.title.y = element_text(size=15), 
axis.text.x=element_text(color="Black",size=10), 
axis.text.y = element_text(color="Black",size=10), 
plot.title = element_text(size=15,hjust=0.5), 
panel.background = element_rect(fill='White',color='Black')) 
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APPENDIX C 
TIME COURSE VESSEL DIAMETER CHANGE PLOT 
 
The plots that are presented here are used to support Chapter 3. 
Figure C.1 Time course vessel diameter change  
 
 
Figure C.2 Vessel diameter amplitude change at different time point 
 
 
* * * 
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APPENDIX D 
VALIDATION OF USING FITC-D2000 TRACERS AS MIMIC OF LARGE 
SIZE WASTE METABOLITES  
 
The figures serve to validate the tracers that are used in experiments.  
 
Figure D.1 Bio-distribution comparison of A-beta and FITC-d2000 tracers following 
intra-cranial injection  (scale bar: whole brain: top: 500 μm, bottom: 1 mm; magnified 
vessels: 30 μm) 
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Figure D.2 Bio-distribution comparison of A-beta and FITC-d2000 tracers following 
CSF injection (scale bar: whole brain: 1 mm; magnified vasculatures: 50 μm) 
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APPENDIX E 
NO DOSE AND TIME DEPENDENT EFFECT IN LOW DOSE ALCOHOL 
TREATMENT 
 
The figures examine dose- and time- dependent effects of low dose alcohol. 
 
Figure E.1 No dose dependent effect on bio-distribution was found in low dose 
alcohol treatment (2.5 mM – 20 mM; 2 hours post-dose; scale bar: 1 mm) 
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Figure E.2 No dose dependent effect on NO production and eNOS expression was 
found in low dose alcohol treatment (2.5 mM – 20 mM; 2 hours post-dose) 
 
 
 
 
 
Figure E.3 No time dependent (2 hours, 5 days, 15 days and 20 days) effect on bio-
distribution was found in low dose alcohol treatment (5 mM; 2 hours post-dose; scale 
bar: 1 mm)  
 
 
 
 
 
* 
* * * 
* * 
* 
* 
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APPENDIX F 
POSTIVE CONTROL OF TRACER BIODISTRIBUTION COMPARED WITH 
EFFECT OF ALCOHOL 
 
The figure is positive control comparing with effects of low dose alcohol.  
 
Figure F.1 Effect of Nitric Oxide (NO) donor S-Nitroso-N-acetylpenicillamine 
(SNAP: 100 μM, equivalent to 0.02 mg/mL through i.v injection) on tracer 
biodistribution (scale bar: 1 mm) 
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